2013 ESH/ESC Guidelines for the management of arterial hypertension

2003, 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension., J Hypertens, 21, 1011, 10.1097/00004872-200306000-00001

Mancia, 2007, 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)., J Hypertens, 25, 1105, 10.1097/HJH.0b013e3281fc975a

Lewington, 2002, Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual datafor one million adults in 61 prospective studies., Lancet, 360, 1903, 10.1016/S0140-6736(02)11911-8

Britton, 2009, Normal systolic blood pressure and risk of heart failure in US male physicians., Eur J Heart Fail, 11, 1129, 10.1093/eurjhf/hfp141

Kalaitzidis, 2010, Prehypertension: is it relevant for nephrologists Kidney I, nt, 77, 194

2003, J H, ypertens, 21, 707

Brown, 2007, Blood pressure parameters and risk of fatal stroke, NHANES II mortality study., Am J Hypertens, 20, 338, 10.1016/j.amjhyper.2006.08.004

Franklin, 1997, Haemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study., Circulation, 96, 308, 10.1161/01.CIR.96.1.308

Vishram, 2012, J0rgensen T, et al. on behalf of the MORGAM ProjectImpact of Age on the Importance of Systolic and Diastolic Blood Pressures for Stroke Risk: The MOnica, Risk, Genetics, Archiving and Monograph (MORGAM) Project., Hypertension, 60, 1117, 10.1161/HYPERTENSIONAHA.112.201400

Benetos, 1997, Pulse pressure: a predictor of long-term cardiovascular mortality in a French male population., Hypertension, 30, 1410, 10.1161/01.HYP.30.6.1410

Kannel, 1981, Systolic blood pressure arterial rigidity risk of stroke. The Framingham study., JAMA, 245, 1225, 10.1001/jama.1981.03310370017013

Kannel, 2000, Risk stratification in hypertension: new insights from the Framingham Study., Am J Hypertens, 13, 3S, 10.1016/S0895-7061(99)00252-6

Thomas, 2001, Cardiovascular mortality in hypertensive men according to presence of associated risk factors., Hypertension, 37, 1256, 10.1161/01.HYP.37.5.1256

Pickering, 1972, Hypertension. Definitions, natural histories and consequences., Am J Med, 52, 570, 10.1016/0002-9343(72)90049-6

Lurbe, 2009, Management of high blood pressure in children and adolescents: recommendations of the European Society of Hypertension., J Hypertens, 27, 1719, 10.1097/HJH.0b013e32832f4f6b

Pereira, 2009, Differences in prevalence, awareness, treatment and control of hypertension between developing and developed countries., J Hypertens, 27, 963, 10.1097/HJH.0b013e3283282f65

Danon-Hersch, 2009, Prevalence, awareness, treatment and control of high blood pressure in a Swiss city general population: the Co Laus study., Eur J Cardiovasc Prev Rehabil, 16, 66, 10.1097/HJR.0b013e32831e9511

Altun, 2005, Prevalence, awareness, treatment and control of hypertension in Turkey (the Paten T study) in 2003., J Hypertens, 23, 1817, 10.1097/01.hjh.0000176789.89505.59

Tugay Aytekin, 2002, Distribution of blood pressures in Gemlik District, north-west Turkey., Health Soc Care Community, 10, 394, 10.1046/j.1365-2524.2002.00379.x

Efstratopoulos, 2006, Prevalence, awareness, treatment and control of hypertension in Hellas, Greece: the Hypertension Study in General Practice in Hellas (HYPERTENSHELL) national study., Am J Hypertens, 19, 53, 10.1016/j.amjhyper.2005.07.011

Macedo, 2005, Prevalence, awareness, treatment and control of hypertension in Portugal: the PAP study., J Hypertens, 23, 1661, 10.1097/01.hjh.0000179908.51187.de

Psaltopoulou, 2004, Prevalence, awareness, treatment and control of hypertension in a general population sample of adults in the Greek EPIC study., Int J Epidemiol, 33, 1345, 10.1093/ije/dyh249

Sarafidis, 2004, Prevalence, awareness, treatment and control of hypertension in employees offactories of Northern Greece: the Naoussa study., J Hum Hypertens, 18, 623, 10.1038/sj.jhh.1001724

Panagiotakos, 2003, Status and management of hypertension in Greece: role of the adoption of a Mediterranean diet: the Attica study., J Hypertens, 21, 1483, 10.1097/00004872-200308000-00011

Banegas, 2012, Achievement of cardiometabolic targets in aware hypertensive patients in Spain: a nationwide population-based study., Hypertension, 60, 898, 10.1161/HYPERTENSIONAHA.112.193078

Primatesta, 2006, Improvement in hypertension management in England: results from the Health Survey for England 2003., J Hypertens, 24, 1187, 10.1097/01.hjh.0000226210.95936.bc

Meisinger, 2006, Regional disparities of hypertension prevalence and management within Germany., J Hypertens, 24, 293, 10.1097/01.hjh.0000200508.10324.8e

Agyemang, 2006, Prevalence and management of hypertension among Turkish, Moroccan and native Dutch ethnic groups in Amsterdam, the Netherlands: The Amsterdam Health Monitor Survey., J Hypertens, 24, 2169, 10.1097/01.hjh.0000249693.73618.c9

Agyemang, 2005, Prevalence, awareness, treatment and controlofhypertension among Black Surinamese, South Asian Surinamese and White Dutch in Amsterdam, The Netherlands: the SUNSET study., J Hypertens, 23, 1971, 10.1097/01.hjh.0000186835.63996.d4

Scheltens, 2007, Awareness, treatment and control of hypertension: the rule of halves in an era of risk-based treatment of hypertension., J Hum Hypertens, 21, 99, 10.1038/sj.jhh.1002123

Zdrojewski, 2004, Arterial hypertension in Poland in 2002., J Hum Hypertens, 18, 557, 10.1038/sj.jhh.1001739

Cifkova, 2004, Prevalence, awareness, treatment and control of hypertension in the Czech Republic. Results of two nationwide cross-sectional surveys in 19971998 and 20002001, Czech Post-MONICA Study., J Hum Hypertens, 18, 571, 10.1038/sj.jhh.1001686

Scuteri, 2009, Age- and gender-specific awareness, treatment and control of cardiovascular risk factors and subclinical vascular lesions in a founder population: the Sardi NIA Study., Nutr Metab Cardiovasc Dis, 19, 532, 10.1016/j.numecd.2008.11.004

Kastarinen, 2009, Prevalence, awareness and treatment of hypertension in Finland during 1982-2007., J Hypertens, 27, 1552, 10.1097/HJH.0b013e32832c41cd

Falaschetti, 2009, Continued improvement in hypertension management in England: results from the Health Survey for England 2006., Hypertension, 53, 480, 10.1161/HYPERTENSIONAHA.108.125617

Erem, 2009, Prevalence of prehypertension and hypertension and associated risk factors among Turkish adults: Trabzon Hypertension Study., J Public Health (Oxf), 31, 47, 10.1093/pubmed/fdn078

Costanzo, 2008, Prevalence, awareness, treatment and control of hypertension in healthy unrelated male-female pairs of European regions: the dietary habit profile in European communities with different risk of myocardial infarction: the impact of migration as a model of gene-environment interaction project., J Hypertens, 26, 2303, 10.1097/HJH.0b013e328311ce04

Cooper, 2007, Using public health indicators to measure the success of hypertension control., Hypertension, 49, 773, 10.1161/01.HYP.0000259106.77783.f8

Wolf-Maier, 2003, Hypertension prevalence and blood pressure levels in 6 European countries, Canada and the United States., JAMA, 289, 2363, 10.1001/jama.289.18.2363

Redon, 2011, Stroke mortality trends from 1990 to 2006 in 39 countries from Europe and Central Asia: implications for control of high blood pressure., Eur Heart J, 32, 1424, 10.1093/eurheartj/ehr045

Pyorala, 1994, Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension., Eur Heart J, 15, 1300

DAgostino, 2008, General cardiovascular risk profile for use in primary care: the Framingham Heart Study., Circulation, 117, 743, 10.1161/CIRCULATIONAHA.107.699579

Conroy, 2003, Estimation often-year risk of fatal cardiovascular disease in Europe: the SCORE project., Eur Heart J, 24, 987, 10.1016/S0195-668X(03)00114-3

Woodward, 2007, Adding social deprivation and family history to cardiovascular risk assessment: the ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC)., Heart, 93, 172, 10.1136/hrt.2006.108167

Hippisley-Cox, 2008, Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2., BMJ, 336, 1475, 10.1136/bmj.39609.449676.25

Assmann, 2002, Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Munster (PROCAM) study., Circulation, 105, 310, 10.1161/hc0302.102575

Ridker, 2007, Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score., JAMA, 297, 611, 10.1001/jama.297.6.611

Cooney, 2009, Value and limitations of existing scores for the assessment of cardiovascular risk: a review for physicians., J Am Coll Cardiol, 54, 1209, 10.1016/j.jacc.2009.07.020

Perk, 2012, European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention Rehabilitation (EACPR)., Eur Heart J, 33, 1635, 10.1093/eurheartj/ehs092

Sehestedt, 2010, Risk prediction is improved by adding markers of subclinical organ damage to SCORE., Eur Heart J, 31, 883, 10.1093/eurheartj/ehp546

Sehestedt, 2012, Thresholds for pulse wave velocity, urine albumin creatinine ratio and left ventricular mass index using SCORE, Framingham and ESHESC risk charts., J Hypertens, 30, 1928, 10.1097/HJH.0b013e328356c579

Volpe, 2012, Cardiovascular risk assessment beyond systemic coronary risk estimation: a role for organ damage markers., J Hypertens, 30, 1056, 10.1097/HJH.0b013e3283525715

1999, 1999World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension., J Hypertens, 17, 151

2003, Organization, International Society of Hypertension Writing GroupWorld Health Organization (WHO)International Society of Hypertension (ISH) statement on management of hypertension., J Hypertens, 21, 1983

OBrien, 2001, Blood pressure measuring devices: recommendations of the European Society of Hypertension., BMJ, 322, 531, 10.1136/bmj.322.7285.531

Clark, 2012, Association of a difference in systolic blood pressure between arms with vascular disease and mortality: a systematic review and meta-analysis., Lancet, 379, 905, 10.1016/S0140-6736(11)61710-8

Fedorowski, 2010, Orthostatic hypotension predicts all-cause mortality and coronary events in middle-aged individuals (The Malmo Preventive Project)., Eur Heart J, 31, 85, 10.1093/eurheartj/ehp329

Fagard, 2010, Orthostatic hypotension is a more robust predictor of cardiovascular events than night-time reverse dipping in elderly., Hypertension, 56, 56, 10.1161/HYPERTENSIONAHA.110.151654

Trazzi, 1991, Reproducibility of noninvasive and intra-arterial blood pressure monitoring: implications for studies on antihypertensive treatment., J Hypertens, 9, 115, 10.1097/00004872-199102000-00003

Myers, 2010, Measurement of blood pressure in the office: recognizing the problem and proposing the solution., Hypertension, 55, 195, 10.1161/HYPERTENSIONAHA.109.141879

Julius, 2012, Usefulness of heart rate to predict cardiac events in treated patients with high-risk systemic hypertension., Am J Cardiol, 109, 685, 10.1016/j.amjcard.2011.10.025

Benetos, 1999, Influence of heart rate on mortality in a French population: role of age, gender and blood pressure., Hypertension, 33, 44, 10.1161/01.HYP.33.1.44

OBrien, 2005, Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement., J Hypertens, 23, 697, 10.1097/01.hjh.0000163132.84890.c4

Parati, 2010, European Society of Hypertension practice guidelines for home blood pressure monitoring., J Hum Hypertens, 24, 779, 10.1038/jhh.2010.54

Parati, 2008, European Societyof Hypertension Working Groupon Blood Pressure MonitoringEuropean Society of Hypertension guidelines for blood pressure monitoring at home: a summary report of the Second International Consensus Conference on Home Blood Pressure Monitoring., J Hypertens, 26, 1505, 10.1097/HJH.0b013e328308da66

Mancia, 1992, Limited reproducibility of hourly blood pressure values obtained by ambulatory blood pressure monitoring: implications for studies on antihypertensive drugs., J Hypertens, 10, 1531, 10.1097/00004872-199210120-00014

Di Rienzo, 1983, Continuous vs intermittent blood pressure measurements in estimating 24-h average blood pressure., Hypertension, 5, 264, 10.1161/01.HYP.5.2.264

Stergiou, 2012, Automated blood pressure measurement in atrial fibrillation: a systematic review and meta-analysis., J Hypertens, 30, 2074, 10.1097/HJH.0b013e32835850d7

Fagard, 1996, Prediction of the actual awake and asleep blood pressures by various methods of 24h pressure analysis., J Hypertens, 14, 557, 10.1097/00004872-199605000-00003

Octavio, 2010, Time-weighted vs. conventional quantification of 24-h average systolic and diastolic ambulatory blood pressures., J Hypertens, 28, 459, 10.1097/HJH.0b013e328334f220

Omboni, 1998, Reproducibility and clinical value of nocturnal hypotension: prospective evidence from the SAMPLE study. Study on Ambulatory Monitoring of Pressure and Lisinopril Evaluation., J Hypertens, 16, 733, 10.1097/00004872-199816060-00003

Stenehjem, 2004, Reproducibility of blood pressure variability, white-coat effect and dipping pattern in untreated, uncomplicated and newly diagnosed essential hypertension., Blood Press, 13, 214, 10.1080/08037050410021432

Mancia, 2012, Short- and long-term blood pressure variability: present and future., Hypertension, 60, 512, 10.1161/HYPERTENSIONAHA.112.194340

Kario, 2003, Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study., Circulation, 107, 1401, 10.1161/01.CIR.0000056521.67546.AA

Head, 2010, A novel measure of the power of the morning blood pressure surge from ambulatory blood pressure recordings., Am J Hypertens, 23, 1074, 10.1038/ajh.2010.126

White, 1991, Blood pressure load and target organ effects in patients with essential hypertension., J Hypertens, 9, S39

Li, 2006, Ambulatory arterial stiffness index derived from 24-h ambulatory blood pressure monitoring., Hypertension, 47, 359, 10.1161/01.HYP.0000200695.34024.4c

Parati, 2012, What are the real determinants of the ambulatory arterial stiffness index J H, ypertens, 30, 472, 10.1097/HJH.0b013e3283509ae2

Verdecchia, 2012, Day-night dip and early-morning surge in blood pressure in hypertension: prognostic implications., Hypertension, 60, 34, 10.1161/HYPERTENSIONAHA.112.191858

Gaborieau, 2008, Ambulatory blood pressure monitoring vs. self-measurement of blood pressure at home: correlation with target organ damage., J Hypertens, 26, 1919, 10.1097/HJH.0b013e32830c4368

Bliziotis, 2012, Home vs. ambulatory and office blood pressure in predicting target organ damage in hypertension: a systematic review and meta-analysis., J Hypertens, 30, 1289, 10.1097/HJH.0b013e3283531eaf

Staessen, 1999, Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators., JAMA, 282, 539, 10.1001/jama.282.6.539

Clement, 2003, Office vs. Ambulatory Pressure Study InvestigatorsPrognostic value of ambulatory blood-pressure recordings in patients with treated hypertension., N Engl J Med, 348, 2407, 10.1056/NEJMoa022273

Dolan, 2005, Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome study., Hypertension, 46, 156, 10.1161/01.HYP.0000170138.56903.7a

Sega, 2005, Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study., Circulation, 111, 1777, 10.1161/01.CIR.0000160923.04524.5B

Conen, 2008, Noninvasive 24-h ambulatory blood pressure and cardiovascular disease: a systematic review and meta-analysis., J Hypertens, 26, 1290, 10.1097/HJH.0b013e3282f97854

Boggia, 2007, Prognostic accuracy of day vs. night ambulatory blood pressure: a cohort study., Lancet, 370, 1219, 10.1016/S0140-6736(07)61538-4

Fagard, 2008, Daytime and night-time blood pressure as predictors ofdeath and cause-specific cardiovascular events in hypertension., Hypertension, 51, 55, 10.1161/HYPERTENSIONAHA.107.100727

Fagard, 2008, Prognostic significance of ambulatory blood pressure in hypertensive patients with history of cardiovascular disease., Blood Press Monit, 13, 325, 10.1097/MBP.0b013e32831054f5

Minutolo, 2011, Prognostic role of ambulatory blood pressure measurement in patients with nondialysis chronic kidney disease., Arch Intern Med, 171, 1090, 10.1001/archinternmed.2011.230

de la Sierra, 2012, Ambulatory blood pressure monitoring and development of cardiovascular events in high-risk patients included in the Spanish ABPM registry: the CARDIORISC Event study., J Hypertens, 30, 713, 10.1097/HJH.0b013e328350bb40

Hansen, 2011, Predictive role of the night-time blood pressure., Hypertension, 57, 3, 10.1161/HYPERTENSIONAHA.109.133900

Fagard, 2009, Night-day blood pressure ratio and dipping pattern as predictors of death and cardiovascular events in hypertension., J Hum Hypertens, 23, 645, 10.1038/jhh.2009.9

Mancia, 2007, Long-term prognostic value of blood pressure variability in the general population: results of the Pressioni Arteriose Monitorate e Loro Associazioni Study., Hypertension, 49, 1265, 10.1161/HYPERTENSIONAHA.107.088708

Kario, 2001, Stroke prognosis and abnormal nocturnal blood pressure falls in older hypertensives., Hypertension, 38, 852, 10.1161/hy1001.092640

Parati, 2010, Role of home blood pressure telemonitoring in hypertension management: an update., Blood Press Monit, 15, 285, 10.1097/MBP.0b013e328340c5e4

Stergiou, 2011, Hypertension: Does home telemonitoring improve hypertension management Nature Rev N, ephrol, 7, 493

Kikuya, 2008, Day-by-day variability of blood pressure and heart rate at home as a novel predictor of prognosis: the Ohasama study., Hypertension, 52, 1045, 10.1161/HYPERTENSIONAHA.107.104620

Stergiou, 2011, Home blood pressure monitoring in the diagnosis and treatment of hypertension: a systematic review., Am J Hypertens, 24, 123, 10.1038/ajh.2010.194

Stergiou, 2010, Home blood pressure as a cardiovascular outcome predictor: its time to take this method seriously., Hypertension, 55, 1301, 10.1161/HYPERTENSIONAHA.110.150771

Ward, 2012, Home measurement of blood pressure and cardiovascular disease: systematic review and meta-analysis of prospective studies., J Hypertens, 30, 449, 10.1097/HJH.0b013e32834e4aed

Fagard, 2005, Prognostic significance of blood pressure measured in the office, at home and during ambulatory monitoring in older patients in general practice., J Hum Hypertens, 19, 801, 10.1038/sj.jhh.1001903

Mancia, 2006, Long-term risk of mortality associated with selective and combined elevation in office, home and ambulatory blood pressure., Hypertension, 47, 846, 10.1161/01.HYP.0000215363.69793.bb

Mancia, 1983, Effects of blood-pressure measurement by the doctor on patients blood pressure and heart rate., Lancet, 2, 695, 10.1016/S0140-6736(83)92244-4

Parati, 1998, Difference between clinic and daytime blood pressure is not a measure of the white-coat effect., Hypertension, 31, 1185, 10.1161/01.HYP.31.5.1185

Mancia, 1996, White-coat hypertension: misnomers, misconceptions and misunderstandings., What should we do next J Hypertens, 14, 1049

Fagard, 2007, Incidence of cardiovascular events in white-coat, masked and sustained hypertension vs. true normotension: a meta-analysis., J Hypertens, 25, 2193, 10.1097/HJH.0b013e3282ef6185

Staessen, 1994, Ambulatory blood pressure in normotensive and hypertensive subjects: results from an international database., J Hypertens Suppl, 12, S1, 10.1097/00004872-199400127-00001

Dolan, 2004, Determinants of white-coat hypertension., Blood Press Monit, 9, 307, 10.1097/00126097-200412000-00007

Pierdomenico, 2011, Prognostic value of white-coat and masked hypertension diagnosed by ambulatory monitoring in initially untreated subjects: an updated meta analysis., Am J Hypertens, 24, 52, 10.1038/ajh.2010.203

Franklin, 2012, Significance of white-coat hypertension in older persons with isolated systolic hypertension: a meta-analysis using the International Database on Ambulatory Blood Pressure Monitoring in Relation to Cardiovascular Outcomes population., Hypertension, 59, 564, 10.1161/HYPERTENSIONAHA.111.180653

Sega, 2001, Alterations of cardiac structure in patients with isolated office, ambulatory, or home hypertension: Data from the general population (Pressione Arteriose Monitorate E Loro Associazioni PAMELA Study)., Circulation, 104, 1385, 10.1161/hc3701.096100

Mancia, 2009, Increased long-term risk of new-onset diabetes mellitus in white-coat and masked hypertension., J Hypertens, 27, 1672, 10.1097/HJH.0b013e32832be5f9

Mancia, 2009, Long-term risk of sustained hypertension in white-coat or masked hypertension., Hypertension, 54, 226, 10.1161/HYPERTENSIONAHA.109.129882

Bobrie, 2008, Masked hypertension: a systematic review., J Hypertens, 26, 1715, 10.1097/HJH.0b013e3282fbcedf

Ogedegbe, 2010, Masked hypertension: evidence of the need to treat., Current Hypertens Rep, 12, 349, 10.1007/s11906-010-0140-4

Lurbe, 2005, Prevalence, persistence and clinical significance of masked hypertension in youth., Hypertension, 45, 493, 10.1161/01.HYP.0000160320.39303.ab

Lurbe, 2002, Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes., N Engl J Med, 347, 797, 10.1056/NEJMoa013410

Wijkman, 2009, Masked nocturnal hypertension: a novel marker of risk in type 2 diabetes., Diabetologia, 52, 1258, 10.1007/s00125-009-1369-9

Hodgkinson, 2011, Relative effectiveness of clinic and home blood pressure monitoring compared with ambulatory blood pressure monitoring in diagnosis of hypertension: systematic review., BMJ, 342, d3621, 10.1136/bmj.d3621

Le, 2008, The blood pressure response to dynamic exercise testing: a systematic review., Prog Cardiovasc Dis, 51, 135, 10.1016/j.pcad.2008.07.001

Smith, 2009, Exercise hypertension: an adverse prognosis J Am Soc H, yper, 3, 366

Huot, 2011, Insulin resistance low cardiorespiratory fitness increased exercise blood pressure: contribution of abdominal obesity., Hypertension, 58, 1036, 10.1161/HYPERTENSIONAHA.111.180349

Sung, 2012, The relationship between arterial stiffness and increase in blood pressure during exercise in normotensive persons., J Hypertens, 30, 587, 10.1097/HJH.0b013e32834f41b1

Holmqvist, 2012, Exercise blood pressure and the risk of future hypertension., J Hum Hypertens, 26, 691, 10.1038/jhh.2011.99

Fagard, 1996, Prognostic value of invasive haemodynamic measurements at restand during exercise in hypertensive men., Hypertension, 28, 31, 10.1161/01.HYP.28.1.31

Kjeldsen, 2001, Supine and exercise systolic blood pressure predict cardiovascular death in middle-aged men., J Hypertens, 19, 1343, 10.1097/00004872-200108000-00001

Sharman, 2011, Association of masked hypertension and left ventricular remodeling with the hypertensive response to exercise., Am J Hypertens, 24, 898, 10.1038/ajh.2011.75

Hedberg, 2009, Augmented blood pressure response to exercise is associated with improved long-term survival in older people., Heart, 95, 1072, 10.1136/hrt.2008.162172

Gupta, 2007, Prognostic significance of systolic blood pressure increases in men during exercise stress testing., Am J Cardiol, 100, 1609, 10.1016/j.amjcard.2007.06.070

Corra, 2012, Cardiopulmonary exercise testing and prognosis in heart failure due to systolic left ventricular dysfunction: a validation study of the European Society of Cardiology Guidelines and Recommendations (2008) and further developments., Eur J Prev Cardiol, 19, 32, 10.1177/1741826710393994

Carroll, 2011, Blood pressure reactions to acute mental stress and future blood pressure status: data from the 12-year follow-up of the West of Scotland Study., Psychosom Med, 73, 737, 10.1097/PSY.0b013e3182359808

Chida, 2010, Greater cardiovascular responses to laboratory mental stress are associated with poor subsequent cardiovascular risk status: a meta-analysis of prospective evidence., Hypertension, 55, 1026, 10.1161/HYPERTENSIONAHA.109.146621

Laurent, 2006, Expert consensus document on arterial stiffness: methodological issues and clinical applications., Eur Heart J, 27, 2588, 10.1093/eurheartj/ehl254

Safar, 2002, Central pulse pressure and mortality in end-stage renal disease., Hypertension, 39, 735, 10.1161/hy0202.098325

Vlachopoulos, 2010, Prediction of cardiovascular events and all-cause mortality with central haemodynamics: a systematic review and meta-analysis., Eur Heart J, 31, 1865, 10.1093/eurheartj/ehq024

Mancia, 2009, Re-appraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document., J Hypertens, 27, 2121, 10.1097/HJH.0b013e328333146d

ORourke, 2013, Guidelines on guidelines: focus on isolated systolic hyprtension in youth., J Hypertens, 31, 649, 10.1097/HJH.0b013e32835d8230

Hunt, 1986, A comparison of positive family history definitions for defining risk of future disease., J Chronic Dis, 39, 809, 10.1016/0021-9681(86)90083-4

Friedman, 1988, Precursors of essential hypertension: body weight, alcohol and salt use and parental history of hypertension., Prev Med, 17, 387, 10.1016/0091-7435(88)90038-2

Luft, 2001, Twins in cardiovascular genetic research., Hypertension, 37, 350, 10.1161/01.HYP.37.2.350

Fagard, 1995, Heritability of conventional and ambulatory blood pressures. A study in twins., Hypertension, 26, 919, 10.1161/01.HYP.26.6.919

Lifton, 2001, Molecular mechanisms of human hypertension., Cell, 104, 545, 10.1016/S0092-8674(01)00241-0

Ehret, 2011, Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk., Nature, 478, 103, 10.1038/nature10405

Levy, 1994, Prognostic implications of baseline electrocardiographic features and their serial changes in subjects with left ventricular hypertrophy., Circulation, 90, 1786, 10.1161/01.CIR.90.4.1786

Okin, 2004, Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events., JAMA, 292, 2343, 10.1001/jama.292.19.2343

Fagard, 2004, Prognostic significance of electrocardiographic voltages and their serial changes in elderly with systolic hypertension., Hypertension, 44, 459, 10.1161/01.HYP.0000142169.17298.54

Okin, 2009, Prognostic value of changes in the electrocardiographic strain pattern during antihypertensive treatment: the Losartan Intervention for End-Point Reduction in Hypertension Study (LIFE)., Circulation, 119, 1883, 10.1161/CIRCULATIONAHA.108.812313

Kirchhof, 2009, Early and comprehensive management of atrial fibrillation: executive summary of the proceedings from the 2nd AFNET-EHRA consensus conference research perspectives in AF., Eur Heart J, 30, 2969, 10.1093/eurheartj/ehp235

Kirchhof, 2011, Comprehensive risk reduction in patients with atrial fibrillation: Emerging diagnostic and therapeutic options. Executive summary of the report from the 3rd AFNETEHRA consensus conference., Thromb Haemost, 106, 1012, 10.1160/TH11-07-0517

Reichek, 1981, Left ventricular hypertrophy: relationship of anatomic, echocardiographic and electrocardiographic findings., Circulation, 63, 1391, 10.1161/01.CIR.63.6.1391

Levy, 1990, Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study., N Engl J Med, 322, 1561, 10.1056/NEJM199005313222203

Tsioufis, 2010, Left ventricular hypertrophy as a determinant of renal outcome in patients with high cardiovascular risk., J Hypertens, 28, 2299, 10.1097/HJH.0b013e32833d95fe

Cuspidi, 2002, Role of echocardiography and carotid ultrasonography in stratifying risk in patients with essential hypertension: the Assessment of Prognostic Risk Observational Survey., J Hypertens, 20, 1307, 10.1097/00004872-200207000-00017

Lang, 2006, Recommendations for chamber quantification., Eur J Echocardiogr, 7, 79, 10.1016/j.euje.2005.12.014

Chirinos, 2010, Left ventricular mass: allometric scaling, normative values, effect of obesity and prognostic performance., Hypertension, 56, 91, 10.1161/HYPERTENSIONAHA.110.150250

Armstrong, 2012, LV mass assessed by echocardiography and CMR, cardiovascular outcomes and medical practice., JACCCardiovasc Imaging, 5, 837

Koren, 1991, Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension., Ann Intern Med, 114, 345, 10.7326/0003-4819-114-5-345

Verdecchia, 1995, Adverse prognostic significance of concentric remodeling of the left ventricle in hypertensive patients with normal left ventricular mass., J Am Coll Cardiol, 25, 871, 10.1016/0735-1097(94)00424-O

Muiesan, 2004, Left ventricular concentric geometry during treatment adversely affects cardiovascular prognosis in hypertensive patients., Hypertension, 43, 731, 10.1161/01.HYP.0000121223.44837.de

Hogg, 2004, Heart failure with preserved left ventricular systolic function: epidemiology, clinical characteristics and prognosis., J Am Coll Cardiol, 43, 317, 10.1016/j.jacc.2003.07.046

Aurigemma, 2001, Predictive value of systolic and diastolic function for incident congestive heart failure in the elderly: the cardiovascular health study., J Am Coll Cardiol, 37, 1042, 10.1016/S0735-1097(01)01110-X

Bella, 2002, Mitral ratio of peak early to late diastolic filling velocity as a predictor of mortality in middle-aged and elderly adults: the Strong Heart Study., Circulation, 105, 1928, 10.1161/01.CIR.0000015076.37047.D9

Nagueh, 2009, Recommendations for the evaluation of left ventricular diastolic function by echocardiography., Eur J Echocardiogr, 10, 165, 10.1093/ejechocard/jep007

Redfield, 2003, Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic., JAMA, 289, 194, 10.1001/jama.289.2.194

De Sutter, 2005, Effects of age, gender and left ventricular mass on septal mitral annulus velocity (E) and the ratio of transmitral early peak velocity to E (EE)., Am J Cardiol, 95, 1020, 10.1016/j.amjcard.2005.01.021

Sharp, 2010, Tissue Doppler EEratio is a powerful predictor of primary cardiac events in a hypertensive population: an ASCOT sub-study., Eur Heart J, 31, 747, 10.1093/eurheartj/ehp498

Abhayaratna, 2006, Left atrial size: physiologic determinants and clinical applications., J Am Coll Cardiol, 47, 2357, 10.1016/j.jacc.2006.02.048

Mor-Avi, 2011, Current and evolving echocardiographic techniques for the quantitative evaluation of cardiac mechanics: ASEEAE consensus statement on methodology and indications endorsed by the Japanese Society of Echocardiography., Eur J Echocardiogr, 12, 167, 10.1093/ejechocard/jer021

Galderisi, 2010, Differences of myocardial systolic deformation and correlates of diastolic function in competitive rowers and young hypertensives: a speckle-tracking echocardiography study., J Am Soc Echocardiogr, 23, 1190, 10.1016/j.echo.2010.07.010

Codella, 2012, Improved left ventricular mass quantification with partial voxel interpolation: in vivo and necropsy validation of a novel cardiac MRI segmentation algorithm., Circ Cardiovasc Imaging, 5, 137, 10.1161/CIRCIMAGING.111.966754

Parsai, 2012, Diagnostic and prognostic value of cardiovascular magnetic resonance in nonischaemic cardiomyopathies., J Cardiovasc Magn Reson, 14, 54, 10.1186/1532-429X-14-54

Picano, 2001, Diagnosis of myocardial ischemia in hypertensive patients., J Hypertens, 19, 1177, 10.1097/00004872-200107000-00001

Chin, 2012, Noninvasive diagnostic testing for coronary artery disease in the hypertensive patient: potential advantages of a risk estimation-based algorithm., Am J Hypertens, 25, 1226

Schulman, 1987, Thallium-201 stress imaging in hypertensive patients., Hypertension, 10, 16, 10.1161/01.HYP.10.1.16

Sicari, 2009, Stress Echocardiography Expert Consensus Statement: Executive Summary: European Association of Echocardiography (EAE) (a registered branch of the ESC)., Eur Heart J, 30, 278, 10.1093/eurheartj/ehn492

Greenwood, 2012, Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial., Lancet, 379, 453, 10.1016/S0140-6736(11)61335-4

Cortigiani, 2011, Diagnostic and prognostic value of Doppler echocardiographic coronary flow reserve in the left anterior descending artery in hypertensive and normotensive patients corrected., Heart, 97, 1758, 10.1136/heartjnl-2011-300178

Bots, 1997, Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study., Circulation, 96, 1432, 10.1161/01.CIR.96.5.1432

OLeary, 1999, Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group., N Engl J Med, 340, 14, 10.1056/NEJM199901073400103

Nambi, 2010, Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk: the ARIC (Atherosclerosis Risk In Communities) study., J Am Coll Cardiol, 55, 1600, 10.1016/j.jacc.2009.11.075

Zanchetti, 2002, Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis: principal results of the European Lacidipine Study on Atherosclerosis (ELSA), a randomized, double-blind, long-term trial., Circulation, 106, 2422, 10.1161/01.CIR.0000039288.86470.DD

Touboul, 2004, Mannheim intima-media thickness consensus., Cerebrovasc Dis, 18, 346, 10.1159/000081812

Zanchetti, 2009, Baseline values but nottreatment-induced changes in carotid intima-mediathickness predict incident cardiovascular events in treated hypertensive patients: findings in the European Lacidipine Study on Atherosclerosis (ELSA)., Circulation, 120, 1084, 10.1161/CIRCULATIONAHA.108.773119

Peters, 2012, Improvements in risk stratification for the occurrence of cardiovascular disease by imaging subclinical atherosclerosis: a systematic review., Heart, 98, 177, 10.1136/heartjnl-2011-300747

Safar, 2003, Current perspectives on arterial stiffness and pulse pressure in hypertension and cardiovascular diseases., Circulation, 107, 2864, 10.1161/01.CIR.0000069826.36125.B4

Van Bortel, 2012, Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity., J Hypertens, 30, 445, 10.1097/HJH.0b013e32834fa8b0

Laurent, 2001, Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients., Hypertension, 37, 1236, 10.1161/01.HYP.37.5.1236

Vlachopoulos, 2010, Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis., J Am Coll Cardiol, 55, 1318, 10.1016/j.jacc.2009.10.061

Boutouyrie, 2002, Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study., Hypertension, 39, 10, 10.1161/hy0102.099031

Mattace-Raso, 2006, Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study., Circulation, 113, 657, 10.1161/CIRCULATIONAHA.105.555235

Mitchell, 2010, Arterial stiffness and cardiovascular events: the Framingham Heart Study., Circulation, 121, 505, 10.1161/CIRCULATIONAHA.109.886655

Feringa, 2006, The long-term prognostic value of the resting and postexercise ankle-brachial index., Arch Intern Med, 166, 529, 10.1001/archinte.166.5.529

Fowkes, 2008, Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis., JAMA, 300, 197, 10.1001/jama.300.2.197

De Buyzere, 2008, Management of hypertension in peripheral arterial disease., Prog Cardiovasc Dis, 50, 238, 10.1016/j.pcad.2007.08.001

Park, 2001, Small artery remodeling is the most prevalent (earliest) form of target organ damage in mild essential hypertension., J Hypertens, 19, 921, 10.1097/00004872-200105000-00013

Schofield, 2002, Vascular structural and functional changes in type 2 diabetes mellitus: evidence for the roles of abnormal myogenic responsiveness and dyslipidemia., Circulation, 106, 3037, 10.1161/01.CIR.0000041432.80615.A5

Rizzoni, 2003, Prognostic significance of small-artery structure in hypertension., Circulation, 108, 2230, 10.1161/01.CIR.0000095031.51492.C5

Greenland, 2010, 2010ACCFAHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology FoundationAmerican Heart Association Task Force on Practice Guidelines., Circulation, 122, e584

Perrone-Filardi, 2011, Cardiac computed tomography and myocardial perfusion scintigraphy for risk stratification in asymptomatic individuals without known cardiovascular disease: a position statement of the Working Group on Nuclear Cardiology and Cardiac CT of the European Society of Cardiology., Eur Heart J, 32, 1986, 10.1093/eurheartj/ehq235

Lerman, 2005, Endothelial function: cardiac events., Circulation, 111, 363, 10.1161/01.CIR.0000153339.27064.14

Versari, 2009, Endothelial dysfunction as a target for prevention of cardiovascular disease., Diabetes Care, 32, S314, 10.2337/dc09-S330

Stevens, 2006, Assessing kidney function: measured and estimated glomerular filtration rate., N Engl J Med, 354, 2473, 10.1056/NEJMra054415

Hallan, 2004, Validation of the Modification of Diet in Renal Disease formula for estimating GFR with special emphasis on calibration of the serum creatinine assay., Am J Kidney Dis, 44, 84, 10.1053/j.ajkd.2004.03.027

Matsushita, 2012, Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estmated glomerular filtration rate., JAMA, 307, 1941, 10.1001/jama.2012.3954

Levey, 2005, Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)., Kidney Int, 67, 2089, 10.1111/j.1523-1755.2005.00365.x

Moe, 2006, Definition, evaluation and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)., Kidney Int, 69, 1945, 10.1038/sj.ki.5000414

Shlipak, 2006, Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease., Ann Intern Med, 145, 237, 10.7326/0003-4819-145-4-200608150-00003

Culleton, 1999, Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency., Kidney Int, 56, 2214, 10.1046/j.1523-1755.1999.00773.x

Parving, 1996, Initiation and progression of diabetic nephropathy., N Engl J Med, 335, 1682, 10.1056/NEJM199611283352212

Ruilope, 1993, Clinical relevance of proteinuria and microalbuminuria., Curr Opin Nephrol Hypertens, 2, 962, 10.1097/00041552-199311000-00017

Redon, 2002, Microalbuminuria in essential hypertension: redefining the threshold., J Hypertens, 20, 353, 10.1097/00004872-200203000-00002

Jensen, 2000, Arterial hypertension, microalbuminuria and risk of ischemic heart disease., Hypertension, 35, 898, 10.1161/01.HYP.35.4.898

de Leeuw, 2004, Clinical significance of renal function in hypertensive patients at high risk: results from the INSIGHT trial., Arch Intern Med, 164, 2459, 10.1001/archinte.164.22.2459

Sarnak, 2003, Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology and Epidemiology and Prevention., Circulation, 108, 2154, 10.1161/01.CIR.0000095676.90936.80

Gerstein, 2001, Albuminuria and risk of cardiovascular events, death and heart failure in diabetic and nondiabetic individuals., JAMA, 286, 421, 10.1001/jama.286.4.421

Wachtell, 2003, Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study., Ann Intern Med, 139, 901, 10.7326/0003-4819-139-11-200312020-00008

Jager, 1999, Microalbuminuria and peripheral arterial disease are independent predictors of cardiovascular and all-cause mortality, especially among hypertensive subjects: five-year follow-up of the Hoorn Study., Arterioscler Thromb Vac Biol, 19, 617, 10.1161/01.ATV.19.3.617

Bigazzi, 1998, Microalbuminuria predicts cardiovascular events and renal insufficiency in patients with essential hypertension., J Hypertens, 16, 1325, 10.1097/00004872-199816090-00014

2004, Executive summary., Am J Kid Dis, 43, S16

Arnlov, 2005, Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study., Circulation, 112, 969, 10.1161/CIRCULATIONAHA.105.538132

Hillege, 2002, Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population., Circulation, 106, 1777, 10.1161/01.CIR.0000031732.78052.81

Ninomiya, 2009, Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes., J Am Soc Nephrol, 20, 1813, 10.1681/ASN.2008121270

Matsushita, 2010, Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis., Lancet, 375, 2073, 10.1016/S0140-6736(10)60674-5

Zanchetti, 2001, Effects of individual risk factors on the incidence of cardiovascular events in the treated hypertensive patients of the Hypertension Optimal Treatment Study. HOT Study Group., J Hypertens, 19, 1149, 10.1097/00004872-200106000-00021

Ruilope, 2001, Renal function and intensive lowering of blood pressure in hypertensive participants of the hypertension optimal treatment (HOT) study., J Am Soc Nephrol, 12, 218, 10.1681/ASN.V122218

De Leeuw, 2002, Prognostic significance of renal function in elderly patients with isolated systolic hypertension: results from the Syst-Eur trial., J Am Soc Nephrol, 13, 2213, 10.1097/01.ASN.0000027871.86296.92

Segura, 2004, On the importance of estimating renal function for cardiovascular risk assessment., J Hypertens, 22, 1635, 10.1097/00004872-200409000-00001

Rahman, 2006, Cardiovascular outcomes in high-risk hypertensive patients stratified by baseline glomerular filtration rate., Ann Intern Med, 144, 172, 10.7326/0003-4819-144-3-200602070-00005

Breslin, 1966, 2nd, Kearns TP. Prognostic importance of ophthalmoscopic findings in essential hypertension., JAMA, 195, 335, 10.1001/jama.1966.03100050043015

Frant, 1950, Prognosis of vascular hypertension; a 9 year follow-up study of 418 cases., Arch Intern Med (Chic), 85, 727, 10.1001/archinte.1950.00230110002001

Wong, 2004, Hypertensive retinopathy., N Engl J Med, 351, 2310, 10.1056/NEJMra032865

Sairenchi, 2011, Mild retinopathy is a risk factor for cardiovascular mortality in Japanese with and without hypertension: the Ibaraki Prefectural Health Study., Circulation, 124, 2502, 10.1161/CIRCULATIONAHA.111.049965

Mollentze, 1990, Ophthalmoscopy vs. nonmydriaticfundus photography inthe detection ofdiabetic retinopathy in black patients., SAfr Medj, 78, 248

Dimmitt, 1989, Usefulness of ophthalmoscopy in mild to moderate hypertension., Lancet, 1, 1103, 10.1016/S0140-6736(89)92384-2

van den Born, 2005, Value of routine funduscopy in patients with hypertension: systematic review., BMJ, 331, 73, 10.1136/bmj.331.7508.73

McGeechan, 2009, Prediction of incident stroke events based on retinal vessel caliber: a systematic review and individual-participant meta-analysis., Am J Epidemiol, 170, 1323, 10.1093/aje/kwp306

Antonios, 1999, Rarefaction of skin capillaries in borderline essential hypertension suggests an early structural abnormality., Hypertension, 34, 655, 10.1161/01.HYP.34.4.655

Noon, 1997, Impaired microvascular dilatation and capillary rarefaction in young adults with a predisposition to high blood pressure., J Clin Invest, 99, 1873, 10.1172/JCI119354

Cuspidi, 2004, Retinal microvascular changes and target organ damage in untreated essential hypertensives., J Hypertens, 22, 2095, 10.1097/00004872-200411000-00010

Hubbard, 1999, Methods for evaluation of retinal microvascular abnormalities associated with hypertensionsclerosis in the Atherosclerosis Risk in Communities Study., Ophthalmology, 106, 2269, 10.1016/S0161-6420(99)90525-0

Ikram, 2004, Are retinal arteriolar or venular diameters associated with markers for cardiovascular disorders The Rotterdam Study., Invest Ophthalmol Vis Sci, 45, 2129, 10.1167/iovs.03-1390

Wong, 2004, Computer-assisted measurement of retinal vessel diameters inthe Beaver Dam Eye Study: methodology, correlation between eyes and effect of refractive errors., Ophthalmology, 111, 1183, 10.1016/j.ophtha.2003.09.039

Sun, 2008, Retinal vascular caliber, blood pressure and cardiovascular risk factors in an Asian population: the Singapore Malay Eye Study., Invest Ophthalmol Vis Sci, 49, 1784, 10.1167/iovs.07-1450

Lehmann, 2011, Remodeling of retinal small arteries in hypertension., Am J Hypertens, 24, 1267, 10.1038/ajh.2011.166

Longstreth, 1996, Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study., Stroke, 27, 1274, 10.1161/01.STR.27.8.1274

de Leeuw, 2002, Hypertension and cerebral white matter lesions in a prospective cohort study., Brain, 125, 765, 10.1093/brain/awf077

Vermeer, 2007, Silent brain infarcts: a systematic review., Lancet Neurology, 6, 611, 10.1016/S1474-4422(07)70170-9

Wong, 2002, Cerebralwhite matter lesions, retinopathyand incidentclinicalstroke., JAMA, 288, 67, 10.1001/jama.288.1.67

Buyck, 2009, Cerebralwhite matter lesions are associated with the risk of stroke but not with other vascular events: the 3-City Dijon Study., Stroke, 40, 2327, 10.1161/STROKEAHA.109.548222

Kearney-Schwartz, 2009, Vascular structure and function is correlated to cognitive performance and white matter hyperintensities in older hypertensive patients with subjective memory complaints., Stroke, 40, 1229, 10.1161/STROKEAHA.108.532853

Henskens, 2009, Detection of silent cerebrovascular disease refines risk stratification of hypertensive patients., J Hypertens, 27, 846, 10.1097/HJH.0b013e3283232c96

Stewart, 2009, Change in blood pressure and incident dementia: a 32-year prospective study., Hypertension, 54, 233, 10.1161/HYPERTENSIONAHA.109.128744

Skoog, 1996, Persson G, Oden A, Svanborg A. 15-year longitudinal study of blood pressure and dementia., Lancet, 347, 1141, 10.1016/S0140-6736(96)90608-X

Kilander, 1998, Hypertension is related to cognitive impairment: a 20-year follow-up of 999 men., Hypertension, 31, 780, 10.1161/01.HYP.31.3.780

Collins, 1994, Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease., Br Med Bull, 50, 272, 10.1093/oxfordjournals.bmb.a072892

Devereux, 2004, Prognostic significance of left ventricular mass change during treatment of hypertension., JAMA, 292, 2350, 10.1001/jama.292.19.2350

Ibsen, 2005, Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: losartan intervention forendpoint reduction in hypertension study., Hypertension, 45, 198, 10.1161/01.HYP.0000154082.72286.2a

Sytkowski, 1996, Secular trends in long-term sustained hypertension, long-term treatment and cardiovacsular mortality. The Framngham Heart Study 1950 to 1990., Circulation, 93, 697, 10.1161/01.CIR.93.4.697

Chobanian, 2003, Seventh report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure., Hypertension, 42, 1206, 10.1161/01.HYP.0000107251.49515.c2

Zanchetti, 2009, When should antihypertensive drug treatment be initiated and to what levels should systolic blood pressure be lowered A critical re-appraisal., J Hypertens, 27, 923, 10.1097/HJH.0b013e32832aa6b5

1985, MRC trial on treatment of mild hypertension: principal results., Br Med J, 291, 97, 10.1136/bmj.291.6488.97

1980, , Lancet, 1, 1261

1982, The effect of treatment on mortality in mild hypertension: results of the Hypertension Detection and Follow- up Program., N Engl J Med, 307, 976, 10.1056/NEJM198210143071603

Liu, 2005, The Felodipine Event Reduction (FEVER) Study: a randomized long-term placebo-controlled trial in Chinese hypertensive patients., J Hypertens, 23, 2157, 10.1097/01.hjh.0000194120.42722.ac

Zhang, 2011, Is a systolic blood pressure target 140mmHg indicated in all hypertensives Subgroup analyses of findings from the randomized FEVER trial., Eur Heart J, 32, 1500, 10.1093/eurheartj/ehr039

Zanchetti, 2009, Bottom blood pressure or bottom cardiovascular risk How far can cardiovascular risk be reduced J H, ypertens, 27, 1509, 10.1097/HJH.0b013e32832e9500

Aronow, 2011, ACCFAHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus documents developed in collaboration with the American Academy of Neurology, American Geriatrics Society, American Society for Preventive Cardiology, American Society of Hypertension, American Society of Nephrology, Association of Black Cardiologists and European Society of Hypertension., J Am Coll Cardiol, 57, 2037, 10.1016/j.jacc.2011.01.008

Schrier, 2002, Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes., Kidney Int, 61, 1086, 10.1046/j.1523-1755.2002.00213.x

2000, Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE sub-study., Lancet, 355, 253, 10.1016/S0140-6736(99)12323-7

2007, 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial., Lancet, 370, 829, 10.1016/S0140-6736(07)61303-8

2008, Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose tolerance or impaired fasting glucose: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial., Diabetes Care, 31, 1007, 10.2337/dc07-1868

2010, N Eng J M, ed, 362, 1477

1995, A preliminary result., Chin Med J (Engl), 108, 710

Arima, 2006, Lower target blood pressures are safe and effective for the prevention of recurrent stroke: the PROGRESS trial., J Hypertens, 24, 1201, 10.1097/01.hjh.0000226212.34055.86

Czernichow, 2011, The effects of blood pressure reduction and of different blood pressure-lowering regimens on major cardiovascular events according to baseline blood pressure: meta-analysis of randomized trials., J Hypertens, 29, 4, 10.1097/HJH.0b013e32834000be

Thompson, 2011, Antihypertensive treatment and secondary prevention of cardiovascular disease events among persons without hypertension: a meta-analysis., JAMA, 305, 913, 10.1001/jama.2011.250

Sipahi, 2012, Effect of antihypertensive therapy on incident stroke in cohorts with prehypertensive blood pressure levels: a meta-analysis of randomized controlled trials., Stroke, 43, 432, 10.1161/STROKEAHA.111.636829

Law, 2009, Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies., BMJ, 338, b1665, 10.1136/bmj.b1665

Julius, 2006, Feasibility of treating prehypertension with an angiotensin receptor blocker., N Engl J Med, 354, 1685, 10.1056/NEJMoa060838

Luders, 2008, The PHARAO Study: prevention of hypertension with the angiotensin converting enzyme inhibitor ramipril in patients with high normal blood pressure: a prospective, randomized, controlled prevention trial of the German Hypertension League., J Hypertens, 26, 1487, 10.1097/HJH.0b013e3282ff8864

Beckett, 2008, Treatment of hypertension in patients 80 years of age or older., N Engl J Med, 358, 1887, 10.1056/NEJMoa0801369

2008, Hypertens R, es, 31, 2115

Ogihara, 2010, Target blood pressure for treatment of isolated systolic hypertension in the elderly: Valsartan in Elderly Isolated Systolic Hypertension Study., Hypertension, 56, 196, 10.1161/HYPERTENSIONAHA.109.146035

Hansson, 1998, Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group., Lancet, 351, 1755, 10.1016/S0140-6736(98)04311-6

Curb, 1996, Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Co-operative Research Group., JAMA, 276, 1886, 10.1001/jama.1996.03540230036032

Tuomilehto, 1999, Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. Systolic Hypertension in Europe Trial Investigators., N Engl J Med, 340, 677, 10.1056/NEJM199903043400902

1998, 2 diabetes: UKPDS 38., Br Med J, 317, 703

Reboldi, 2011, Effects of intensive blood pressure reduction on myocardial infarction and stroke in diabetes: a meta-analysis in patients., J Hypertens, 29, 1253, 10.1097/HJH.0b013e3283469976

2010, 2 diabetes mellitus., N Engl J Med, 362, 1575

2001, 6105 individuals with previous stroke or transient ischaemic attack., Lancet, 358, 1033, 10.1016/S0140-6736(01)06178-5

Yusuf, 2008, Telmisartan to prevent recurrent stroke and cardiovascular events., N Engl J Med, 359, 1225, 10.1056/NEJMoa0804593

2003, Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study)., Lancet, 362, 782, 10.1016/S0140-6736(03)14286-9

Nissen, 2004, Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial., JAMA, 292, 2217, 10.1001/jama.292.18.2217

Pitt, 2000, Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. PREVENT Investigators., Circulation, 102, 1503, 10.1161/01.CIR.102.13.1503

Poole-Wilson, 2004, Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trial., Lancet, 364, 849, 10.1016/S0140-6736(04)16980-8

2004, N Engl J M, ed, 351, 2058

Lewis, 2010, Blood pressure control in chronic kidney disease: is less really more J Am Soc N, ephrol, 21, 1086

Klahr, 1994, The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group., N Engl J Med, 330, 877, 10.1056/NEJM199403313301301

Wright, 2002, Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial., JAMA, 288, 2421, 10.1001/jama.288.19.2421

Ruggenenti, 2005, Blood-pressure controlfor renoprotection in patients with nondiabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial., Lancet, 365, 939, 10.1016/S0140-6736(05)71082-5

Sarnak, 2005, The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the modification of diet in renal disease study., Ann Intern Med, 142, 342, 10.7326/0003-4819-142-5-200503010-00009

Appel, 2010, Intensive blood-pressure control in hypertensive chronic kidney disease., N Engl J Med, 363, 918, 10.1056/NEJMoa0910975

Lewis, 2001, Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes., N Engl J Med, 345, 851, 10.1056/NEJMoa011303

Brenner, 2001, Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy., N Engl J Med, 345, 861, 10.1056/NEJMoa011161

2009, N Engl J M, ed, 361, 1639

Upadhyay, 2011, Systematic review: blood pressure target in chronic kidney disease and proteinuria as an effect modifier., Ann Intern Med, 154, 541, 10.7326/0003-4819-154-8-201104190-00335

Zanchetti, 2010, Blood pressure targets of antihypertensive treatment: up and down the J-shaped curve., Eur Heart J, 31, 2837, 10.1093/eurheartj/ehq281

Adler, 2000, Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study., BMJ, 321, 412, 10.1136/bmj.321.7258.412

Berl, 2005, Impact of achieved blood pressure on cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial., J Am Soc Nephrol, 16, 2170, 10.1681/ASN.2004090763

Messerli, 2006, Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous Ann Intern M, ed, 144, 884

Sleight, 2009, Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study., J Hypertens, 27, 1360, 10.1097/HJH.0b013e32832d7370

Okin, 2012, Impact of lower achieved blood pressure on outcomes in hypertensive patients., J Hypertens, 30, 802, 10.1097/HJH.0b013e3283516499

Boutitie, 2002, J-shaped relationship between blood pressure and mortality in hypertensive patients: new insights from a meta-analysis of individual-patient data., Ann Intern Med, 136, 438, 10.7326/0003-4819-136-6-200203190-00007

Fagard, 2007, On-treatment diastolic blood pressure and prognosis in systolic hypertension., Arch Intern Med, 167, 1884, 10.1001/archinte.167.17.1884

Bangalore, 2009, Treating to New Targets Steering Committee and InvestigatorsJ-Curve revisited: an analysis of the Treating to New Targets (TNT) Trial., J Am Coll Cardiol, 53, A217

Bangalore, 2010, What is the optimal blood pressure in patients after acute coronary syndromes: Relationship of blood pressure and cardiovascular events in the PRavastatin OR ator Vastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction (PROVE IT-TIMI) 22 trial., Circulation, 122, 2142, 10.1161/CIRCULATIONAHA.109.905687

Mancia, 2011, Blood pressure targets recommended by guidelines and incidence of cardiovascular and renal events in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial (ONTARGET)., Circulation, 124, 1727, 10.1161/CIRCULATIONAHA.110.008870

Ovbiagele, 2011, Level of systolic blood pressure within the normal range and risk of recurrent stroke., JAMA, 306, 2137, 10.1001/jama.2011.1650

Redon, 2012, Safety and efficacy of low blood pressures among patients with diabetes: subgroup analyses fromthe ONTARGET (ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial)., J Am Coll Cardiol, 59, 74, 10.1016/j.jacc.2011.09.040

Bangalore, 2011, Blood pressure targets in subjects with type 2 diabetes mellitusimpaired fasting glucose: observations from traditional and bayesian random-effects meta-analyses of randomized trials., Circulation, 123, 2799, 10.1161/CIRCULATIONAHA.110.016337

Verdecchia, 2009, Usual vs. tight control of systolic blood pressure in nondiabetic patients with hypertension (Cardio-Sis): an open-label randomised trial., Lancet, 374, 525, 10.1016/S0140-6736(09)61340-4

Haller, 2011, ROADMAP Trial InvestigatorsOlmesartan for the delay or prevention of microalbuminuria in type 2 diabetes., N Engl J Med, 364, 907, 10.1056/NEJMoa1007994

Okin, 2003, Regression of electrocardiographic left ventricular hypertrophy by losartan vs. atenolol: The Losartan Intervention for Endpoint reduction in Hypertension (LIFE) Study., Circulation, 108, 684, 10.1161/01.CIR.0000083724.28630.C3

Mann, 2008, Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial., Lancet, 372, 547, 10.1016/S0140-6736(08)61236-2

Zanchetti, 2012, Longing for clinical excellence: a critical outlook into the NICE recommendations on hypertension management: is nice always good J H, ypertens, 30, 660, 10.1097/HJH.0b013e328351b4e4

Mancia, 2012, Ambulatory Blood Pressure Values in the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial (ONTARGET)., Hypertension, 60, 1400, 10.1161/HYPERTENSIONAHA.112.199562

Staessen, 1997, Antihypertensive treatment based on conventional or ambulatory blood pressure measurement. A randomized controlled trial. Ambulatory Blood Pressure Monitoring and Treatment of Hypertension Investigators., JAMA, 278, 1065, 10.1001/jama.1997.03550130039034

Staessen, 2004, Antihypertensive treatment based on blood pressure measurement at home or in the physicians office: a randomized controlled trial., JAMA, 291, 955, 10.1001/jama.291.8.955

Verberk, 2007, Self-measurement of blood pressure at home reduces the need for antihypertensive drugs: a randomized, controlled trial., Hypertension, 50, 1019, 10.1161/HYPERTENSIONAHA.107.094193

Elmer, 2006, Effects of comprehensive lifestyle modification on diet, weight, physical fitness and blood pressure control: 18-month results of a randomized trial., Ann Intern Med, 144, 485, 10.7326/0003-4819-144-7-200604040-00007

Frisoli, 2011, Beyond salt: lifestyle modifications and blood pressure., Eur Heart J, 32, 3081, 10.1093/eurheartj/ehr379

Dickinson, 2006, Lifestyle interventions to reduce raised blood pressure: a systematic review of randomized controlled trials., J Hypertens, 24, 215, 10.1097/01.hjh.0000199800.72563.26

Groppelli, 1990, Blood pressure and heart rate response to repeated smoking before and after beta-blockade and selective alpha 1 inhibition., J Hypertens, 8, S35

Groppelli, 1992, Persistent blood pressure increase induced by heavy smoking., J Hypertens, 10, 495, 10.1097/00004872-199205000-00014

Mann, 1991, Elevation of ambulatory systolic blood pressure in hypertensive smokers. A case-control study., JAMA, 265, 2226, 10.1001/jama.1991.03460170080037

Guild, 2012, High dietary salt and angiotensin II chronically increase renal sympathetic nerve activity: a direct telemetric study., Hypertension, 59, 614, 10.1161/HYPERTENSIONAHA.111.180885

Pimenta, 2009, Effects of dietary sodium reduction on blood pressure in subjects with resistant hypertension: results from a randomized trial., Hypertension, 54, 475, 10.1161/HYPERTENSIONAHA.109.131235

Graudal, 2012, Effects of low-sodium diet vs. high-sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol and triglyceride (Cochrane Review)., Am J Hypertens, 25, 1, 10.1038/ajh.2011.210

He, 2003, How far should salt intake be reduced H, ypertension, 42, 1093, 10.1161/01.HYP.0000102864.05174.E8

Bibbins-Domingo, 2010, Projected effect of dietary salt reductions on future cardiovascular disease., NEngl J Med, 362, 590, 10.1056/NEJMoa0907355

He, 2011, Salt reduction lowers cardiovascular risk: meta-analysis of outcome trials., Lancet, 378, 380, 10.1016/S0140-6736(11)61174-4

Taylor, 2011, Reduced dietary salt for the prevention of cardiovascular disease: a meta-analysis of randomized controlled trials (Cochrane review)., Am J Hypertens, 24, 843, 10.1038/ajh.2011.115

He, 2011, Nutrition in cardiovascular disease: salt in hypertension and heart failure., Eur Heart J, 32, 3073, 10.1093/eurheartj/ehr194

Cook, 2007, Longterm effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP)., BMJ, 334, 885, 10.1136/bmj.39147.604896.55

ODonnell, 2013, Salt intake and cardiovascular disease: why are the data inconsistent Eur Heart, J, 34, 1034

Cobiac, 2010, Cost-effectiveness of interventions to reduce dietary salt intake., Heart, 96, 1920, 10.1136/hrt.2010.199240

Puddey, 1987, Regular alcohol use raises blood pressure in treated hypertensive subjects. A randomised controlled trial., Lancet, 1, 647, 10.1016/S0140-6736(87)90413-2

Cushman, 1998, Prevention and Treatment of Hypertension Study (PATHS): effects of an alcohol treatment program on blood pressure., Arch Intern Med, 158, 1197, 10.1001/archinte.158.11.1197

Mente, 2009, A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease., Arch Intern Med, 169, 659, 10.1001/archinternmed.2009.38

Sofi, 2010, Accruing evidence on benefits of adherencetothe Mediterranean diet on health: an updated systematic review and meta-analysis., Am J Clin Nutr, 92, 1189, 10.3945/ajcn.2010.29673

Estruch, 2013, the PREDIMED Study InvestigatorsPrimary Prevention of Cardiovascular Disease with a Mediterranean Diet., N Eng J Med, 368, 1279, 10.1056/NEJMoa1200303

Rivas, 2002, Soy milk lowers blood pressure in men and women with mild to moderate essential hypertension., J Nutr, 132, 1900, 10.1093/jn/132.7.1900

Blumenthal, 2010, Effects of the DASH diet al. one and in combination with exercise and weight loss on blood pressure and cardiovascular biomarkers in men and women with high blood pressure: the ENCORE study., Arch Intern Med, 170, 126, 10.1001/archinternmed.2009.470

Stessen, 2012, The effect of coffee consumption on blood pressure and the development of hypertension: a systematic review and meta-analysis., J Hypertens, 30, 2245, 10.1097/HJH.0b013e3283588d73

Romero, 2007, Undiagnosed obesity in hypertension: clinical and therapeutic implications., Blood Press, 16, 347, 10.1080/08037050701715117

Neter, 2003, Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials., Hypertension, 42, 878, 10.1161/01.HYP.0000094221.86888.AE

2009, 900000 adults: collaborative analyses of 57 prospective studies., Lancet, 373, 1083, 10.1016/S0140-6736(09)60318-4

Flegal, 2013, Association of all-cause mortality with overweight and obesity using standard body mass index categories. A systematic review and meta-analysis., JAMA, 309, 71, 10.1001/jama.2012.113905

Jordan, 2012, Joint statement of the European Association for the Study of Obesity and the European Society of Hypertension: obesity and difficult to treat arterial hypertension., J Hypertens, 30, 1047, 10.1097/HJH.0b013e3283537347

Cornelissen, 2005, Effects of endurance training on blood pressure, blood pressure-regulating mechanisms and cardiovascular risk factors., Hypertension, 46, 667, 10.1161/01.HYP.0000184225.05629.51

Leitzmann, 2007, Physical activity recommendations and decreased risk of mortality., Archlntern Med, 167, 2453

Rossi, 2012, The impact of physical activity on mortality in patients with high blood pressure: a systematic review., J Hypertens, 30, 1277, 10.1097/HJH.0b013e3283544669

Fagard, 2012, Physical activity, fitness, mortality., J Hypertens, 30, 1310, 10.1097/HJH.0b013e3283551eb2

Fagard, 2011, Exercise therapy in hypertensive cardiovascular disease., Prog Cardiovasc Dis, 53, 404, 10.1016/j.pcad.2011.03.006

Molmen-Hansen, 2012, Aerobic interval training reduces blood pressure and improves myocardial function in hypertensive patients., Eur J Prev Cardiol, 19, 151, 10.1177/1741826711400512

Cornelissen, 2011, Impactofresistance trainingon blood pressure and other cardiovascular risk factors: a meta-analysis ofrandomized, controlled trials., Hypertension, 58, 950, 10.1161/HYPERTENSIONAHA.111.177071

Vanhees, 2012, Importance of characteristics and modalities of physical activity and exercise inthe management of cardiovascular health in individuals with cardiovascular risk factors: recommendations from the EACPR. Part II., Eur J Prev Cardiol, 19, 1005, 10.1177/1741826711430926

Huisman, 2005, Inequalities in the prevalence of smoking in the European Union: comparing education and income., Prev Med, 40, 756, 10.1016/j.ypmed.2004.09.022

Yarlioglues, 2010, Acute effects of passive smoking on blood pressure and heart rate in healthy females., Blood Press Monit, 15, 251, 10.1097/MBP.0b013e32833e439f

Grassi, 1994, Mechanisms responsible for sympathetic activation by cigarette smoking in humans., Circulation, 90, 248, 10.1161/01.CIR.90.1.248

Narkiewicz, 1998, Cigarette smoking increases sympathetic outflow in humans., Circulation, 98, 528, 10.1161/01.CIR.98.6.528

Mancia, 1997, Smoking impairs baroreflex sensitivity in humans., Am J Physiol, 273, H1555

Bang, 2000, Do we undertreat hypertensive smokers A comparison between smoking and nonsmoking hypertensives., Blood Press Monit, 5, 271, 10.1097/00126097-200010000-00004

Primatesta, 2001, Association between smoking and blood pressure: evidence from the health survey for England., Hypertension, 37, 187, 10.1161/01.HYP.37.2.187

Doll, 1994, Mortality in relation to smoking: 40 years observations on male British doctors., BMJ, 309, 901, 10.1136/bmj.309.6959.901

Rosenberg, 1985, The risk of myocardial infarction after quitting smoking in men under 55 years of age., N Engl J Med, 313, 1511, 10.1056/NEJM198512123132404

Manson, 1992, The primary prevention of myocardial infarction., N Engl J Med, 326, 1406, 10.1056/NEJM199205213262107

Psaty, 2003, Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis., JAMA, 289, 2534, 10.1001/jama.289.19.2534

Costanzo, 2009, Calcium channel blockers and cardiovascular outcomes: a meta-analysis of 175634 patients., J Hypertens, 27, 1136, 10.1097/HJH.0b013e3283281254

van Vark, 2012, Angiotensin-converting enzyme inhibitors reduce mortality in hypertension: a meta-analysis of randomized clinical trials of renin-angiotensin-aldosterone system inhibitors involving 158998 patients., Eur Heart J, 33, 2088, 10.1093/eurheartj/ehs075

2005, Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials., Arch Intern Med, 165, 1410, 10.1001/archinte.165.12.1410

2003, Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively- designed overviews ofrandomised trials., Lancet, 362, 1527, 10.1016/S0140-6736(03)14739-3

Bradley, 2006, How strong is the evidence for use of beta-blockers as first line therapy for hypertension J H, ypertens, 24, 2131, 10.1097/01.hjh.0000249685.58370.28

Williams, 2006, Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study., Circulation, 113, 1213, 10.1161/CIRCULATIONAHA.105.595496

Boutouyrie, 2010, Amlodipine-valsartan combination decreases central systolic blood pressure more effectively than the amlodipine-atenolol combination: the EXPLOR study., Hypertension, 55, 1314, 10.1161/HYPERTENSIONAHA.109.148999

Silvestri, 2003, Report of erectile dysfunction after therapy with beta-blockers is related to patient knowledge of side- effects and is reversed by placebo., Eur Heart J, 24, 1928, 10.1016/j.ehj.2003.08.016

Sharma, 2001, Hypothesis: Beta-adrenergic receptor blockers and weight gain: A systematic analysis., Hypertension, 37, 250, 10.1161/01.HYP.37.2.250

Elliott, 2007, Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis., Lancet, 369, 201, 10.1016/S0140-6736(07)60108-1

Zanchetti, 2007, Prevalence and incidence of the metabolic syndrome in the European Lacidipine Study on Atherosclerosis (ELSA) and its relation with carotid intima-media thickness., J Hypertens, 25, 2463, 10.1097/HJH.0b013e3282f063d5

Boutouyrie, 2000, Local pulse pressure and regression of arterial wall hypertrophy during long-term antihypertensive treatment., Circulation, 101, 2601, 10.1161/01.CIR.101.22.2601

Dhakam, 2008, Yasmin, McEniery CM, Burton T, Brown MJ, Wilkinson IB. A comparison of atenolol and nebivolol in isolated systolic hypertension., J Hypertens, 26, 351, 10.1097/HJH.0b013e3282f283c9

Kampus, 2011, Differential effects of nebivolol and metoprolol on central aortic pressure and left ventricular wall thickness., Hypertension, 57, 1122, 10.1161/HYPERTENSIONAHA.110.155507

Bakris, 2004, Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial., JAMA, 292, 2227, 10.1001/jama.292.18.2227

Celik, 2006, Comparative effects of nebivolol and metoprolol on oxidative stress, insulin resistance, plasma adiponectin and soluble P-selectin levels in hypertensive patients., J Hypertens, 24, 591, 10.1097/01.hjh.0000209993.26057.de

Stears, 2012, A double-blind, placebo-controlled, crossover trial comparing the effects of amiloride and hydrochlorothiazide on glucose tolerance in patients with essential hypertension., Hypertension, 59, 934, 10.1161/HYPERTENSIONAHA.111.189381

McMurray, 2012, ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC., Eur Heart J, 33, 1787, 10.1093/eurheartj/ehs104

Rutten, 2010, Beta-Blockers may reduce mortality and risk of exacerbations in patients with chronic obstructive pulmonary disease., Arch Intern Med, 170, 880, 10.1001/archinternmed.2010.112

1977, A co-operative study., JAMA, 237, 255

Jamerson, 2008, Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients., N Engl J Med, 359, 2417, 10.1056/NEJMoa0806182

Zanchetti, 2011, Hypertension meta-analyses: first rank evidence or second hand information Nat Rev C, ardiol, 14, 249

Messerli, 2011, Antihypertensive efficacy of hydrochlorothiazide as evaluated by ambulatory blood pressure monitoring. A meta-analysed of randomized trials., J Am Coll Cardiol, 57, 590, 10.1016/j.jacc.2010.07.053

Roush, 2012, Chlortalidone compared with hydrochlorothiazide in reducing cardiovascular events: systematic review and network meta-analyses., Hypertension, 59, 1110, 10.1161/HYPERTENSIONAHA.112.191106

Dorsch, 2011, Chlortalidone reduces cardiovascular events compared with hydrochlorothiazide: a retrospective cohort analysis., Hypertension, 57, 689, 10.1161/HYPERTENSIONAHA.110.161505

Pitt, 1999, The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators., N Engl J Med, 341, 709, 10.1056/NEJM199909023411001

Zannad, 2011, EMPHASIS-HF Study GroupEplerenone in patients with systolic heart failure and mild symptoms., N Engl J Med, 364, 11, 10.1056/NEJMoa1009492

Verdecchia, 2005, Angiotensin-Converting Enzyme Inhibitorsand Calcium Channel Blockers for Coronary Heart Disease and Stroke Prevention., Hypertension, 46, 386, 10.1161/01.HYP.0000174591.42889.a2

Dalhof, 2005, Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindoprilas required vs. atenolol adding bendroflumethiazide as required in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA) a multicentre randomised controlled trial., Lancet, 366, 895, 10.1016/S0140-6736(05)67185-1

Strauss, 2006, Do angiotensin receptor blockers increase the risk of myocardial infarction: Angiotensin Receptor Blockers May increase risk of Myocardial Infarction: Unraveling the ARB-MI Paradox., Circulation, 114, 838, 10.1161/CIRCULATIONAHA.105.594986

Sipahi, 2010, Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomised controlled trials., The Lancet Oncology, 11, 627, 10.1016/S1470-2045(10)70106-6

2011, Effects of telmisartan, irbesartan, valsartan, candesartan and losartan on cancers in 15 trials enrolling 138769 individuals., J Hypertens, 29, 623, 10.1097/HJH.0b013e328344a7de

Volpe, 2011, Twisting arms to angiotensin receptor blockersantagonists: the turn of cancer., Eur Heart J, 32, 19, 10.1093/eurheartj/ehq382

Gradman, 2005, Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebo-like tolerability in hypertensive patients., Circulation, 111, 1012, 10.1161/01.CIR.0000156466.02908.ED

OBrien, 2007, Aliskiren reduces blood pressure and suppresses plasma renin activity in combination with a thiazide diuretic, an angiotensin-converting enzyme inhibitor, or an angiotensin receptor blocker., Hypertension, 49, 276, 10.1161/01.HYP.0000253780.36691.4f

Littlejohn, 2009, 3rd, Trenkwalder P, Hollanders G, Zhao Y, Liao W. Long-term safety, tolerability and efficacy of combination therapy with aliskiren and amlodipine in patients with hypertension., Curr Med Res Opin, 25, 951, 10.1185/03007990902785845

Parving, 2008, Aliskiren combined with losartan in type 2 diabetes and nephropathy., N Engl J Med, 358, 2433, 10.1056/NEJMoa0708379

Seed, 2007, Neurohumoral effects of the new orally active renin inhibitor, aliskiren, in chronic heart failure., Eurj Heart Fail, 9, 1120, 10.1016/j.ejheart.2007.09.002

Parving, 2012, Cardiorenal endpoints in a trial of aliskiren for type 2 diabetes., N Engl J Med, 367, 2204, 10.1056/NEJMoa1208799

Gheorghiade, 2013, for the ASTRONAUT Investigators and Co-ordinatorsEffect of Aliskiren on Postdischarge Mortality and Heart Failure Readmissions Among Patients Hospitalized for Heart Failure. The ASTRONAUT Randomized Trial., JAMA, 309, 1125, 10.1001/jama.2013.1954

Rothwell, 2010, Prognostic significance of visit-to-visit variability, maximum systolic blood pressure and episodic hypertension., Lancet, 375, 895, 10.1016/S0140-6736(10)60308-X

Mancia, 2007, Blood pressure control and improved cardiovascular outcomes in the International Verapamil SR-Trandolapril Study., Hypertension, 50, 299, 10.1161/HYPERTENSIONAHA.107.090290

Mancia, 2012, Visit-to-Visit Blood Pressure Variability, Carotid Atherosclerosis and Cardiovascular Events in the European Lacidipine Study on Atherosclerosis., Circulation, 126, 569, 10.1161/CIRCULATIONAHA.112.107565

Rothwell, 2010, Effects of beta blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke., Lancet Neurology, 9, 469, 10.1016/S1474-4422(10)70066-1

Webb, 2010, Effects of antihypertensive-drug class on inter-individual variation in blood pressure and risk of stroke: a systematic review and meta-analysis., Lancet, 375, 906, 10.1016/S0140-6736(10)60235-8

Webb, 2011, Effect of dose and combination of antihypertensives on inter-individual blood pressure variability: a systematic review., Stroke, 42, 2860, 10.1161/STROKEAHA.110.611566

Mancia, 2012, Visit-to-visit blood pressure variability in the European Lacidipine Study on Atherosclerosis: methodological aspects and effects of antihypertensive treatment., J Hypertens, 30, 1241, 10.1097/HJH.0b013e32835339ac

Zanchetti, 2011, Wars, war games and dead bodies on the battlefield: variations on the theme of blood pressure variability., Stroke, 42, 2722, 10.1161/STROKEAHA.111.626747

Mancia, 2008, Choice of antihypertensive drugs in the European Society of Hypertension-European Society of Cardiology guidelines: specific indications rather than ranking for general usage., J Hypertens, 26, 164, 10.1097/HJH.0b013e3282f52fa8

2008, Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials., BMJ, 336, 1121, 10.1136/bmj.39548.738368.BE

2008, Eur Heart, j, 29, 2669

Wald, 2009, Combination therapy vs. monotherapy in reducing blood pressure: meta-analysis on 11000 participants from 42 trials., Am JMed, 122, 290

Corrao, 2010, Reduced discontinuation of antihypertensive treatment by two-drug combination as first step. Evidence from daily life practice., J Hypertens, 28, 1584, 10.1097/HJH.0b013e328339f9fa

2002, Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)., JAMA, 288, 2981, 10.1001/jama.288.23.2981

1991, Final results of the Systolic Hypertension in the Elderly Program (SHEP)., JAMA, 265, 3255, 10.1001/jama.1991.03460240051027

Lithell, 2003, The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial., J Hypertens, 21, 875, 10.1097/00004872-200305000-00011

Staessen, 1997, Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators., Lancet, 350, 757, 10.1016/S0140-6736(97)05381-6

Liu, 1998, Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. Systolic Hypertension in China (Syst-China) Collaborative Group., J Hypertens, 16, 1823, 10.1097/00004872-199816120-00016

Coope, 1986, Randomised trial of treatment of hypertension in elderly patients in primary care., BMJ, 293, 1145, 10.1136/bmj.293.6555.1145

Dahlof, 1991, Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension)., Lancet, 338, 1281, 10.1016/0140-6736(91)92589-T

Hansson, 1999, Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial., Lancet, 353, 611, 10.1016/S0140-6736(98)05012-0

Julius, 2004, VALUE trial groupOutcomes inhypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial., Lancet, 363, 2022, 10.1016/S0140-6736(04)16451-9

Dahlof, 2002, LIFE Study GroupCardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol., Lancet, 359, 995, 10.1016/S0140-6736(02)08089-3

Black, 2003, CONVINCE Trial groupPrincipal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial., JAMA, 289, 2073, 10.1001/jama.289.16.2073

Pepine, 2003, INVEST investigatorsA calcium antagonist vs a noncalcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial., JAMA, 290, 2805, 10.1001/jama.290.21.2805

Hansson, 1999, Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study., Lancet, 354, 1751, 10.1016/S0140-6736(99)10327-1

Hansson, 2000, Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study., Lancet, 356, 359, 10.1016/S0140-6736(00)02526-5

Mancia, 2006, New-onset diabetes and antihypertensive drugs., J Hypertens, 24, 3, 10.1097/01.hjh.0000194119.42722.21

2008, Telmisartan, ramipril, or both in patients at high risk for vascular events., N Engl J Med, 358, 1547, 10.1056/NEJMoa0801317

Matsui, 2009, Differential effects between a calcium channel blocker and a diuretic when used in combination with angiotensin II receptor blocker on central aortic pressure in hypertensive patients., Hypertension, 54, 716, 10.1161/HYPERTENSIONAHA.109.131466

Gupta, 2010, Compliance, safety and effectiveness of fixed-dose combinations of antihypertensive agents: a meta-analysis., Hypertension, 55, 399, 10.1161/HYPERTENSIONAHA.109.139816

Claxton, 2001, A systematic review of the association between dose regimens and medication compliance., Clin Ther, 23, 1296, 10.1016/S0149-2918(01)80109-0

2009, TIPS): a phase II, double blind, randomised trial., Lancet, 373, 1341

Fagard, 2000, Response to antihypertensive therapy in older patients with sustained and nonsustained systolic hypertension. Systolic Hypertension in Europe (Syst-Eur) Trial Investigators., Circulation, 102, 1139, 10.1161/01.CIR.102.10.1139

Bjorklund, 2003, Isolated ambulatory hypertension predicts cardiovascular morbidity in elderly men., Circulation, 107, 1297, 10.1161/01.CIR.0000054622.45012.12

Amery, 1985, Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial., Lancet, 1, 1349, 10.1016/S0140-6736(85)91783-0

1992, MRC Working Party., BMJ, 304, 405

Sundstrom, 2011, Association of blood pressure in late adolescence with subsequent mortality: cohort study of Swedish male conscripts., BMJ, 342, d643, 10.1136/bmj.d643

Melloni, 2010, Representation of women in randomized clinical trials of cardiovascular disease prevention., Circulation Cardiovascular quality and outcomes, 3, 135, 10.1161/CIRCOUTCOMES.110.868307

Blauwet, 2007, Low rate of sex-specific result reporting in cardiovascular trials., Mayo Clin Proc, 82, 166, 10.1016/S0025-6196(11)60993-2

Gueyffier, 1997, Effect of antihypertensive drugtreatment on cardiovascular outcomes in women and men. A meta-analysis of individual patient data from randomized, controlled trials. The INDANA Investigators., Ann Intern Med, 126, 761, 10.7326/0003-4819-126-10-199705150-00002

Dong, 1997, Blood pressure in women using oral contraceptives: results from the Health Survey for England 1994., J Hypertens, 15, 1063, 10.1097/00004872-199715100-00003

Chasan-Taber, 1996, Prospective study of oral contraceptives and hypertension among women in the United States., Circulation, 94, 483, 10.1161/01.CIR.94.3.483

Atthobari, 2007, The impact of hormonal contraceptives on blood pressure, urinary albumin excretion and glomerular filtration rate., Br J Clin Pharmacol, 63, 224, 10.1111/j.1365-2125.2006.02747.x

Oelkers, 2005, Drospirenone in combination with estrogens: for contraception and hormone replacement therapy., Climacteric, 8, 19, 10.1080/13697130500330341

Martinez, 2012, Venous and pulmonary thromboembolism and combined hormonal contraceptives. Systematic review and meta-analysis., Eur J Contracept Reprod Healthcare, 17, 7, 10.3109/13625187.2011.643836

Stampfer, 1988, A prospective study of moderate alcohol consumption and the risk of coronary disease and stroke in women., N Engl J Med, 319, 267, 10.1056/NEJM198808043190503

Dunn, 1999, Oral contraceptives and myocardial infarction: results of the MICA case- control study., BMJ, 318, 1579, 10.1136/bmj.318.7198.1579

Tanis, 2001, Oral contraceptives and the risk of myocardial infarction., N Engl J Med, 345, 1787, 10.1056/NEJMoa003216

Margolis, 2007, A prospective study of oral contraceptive use and risk of myocardial infarction among Swedish women., Fertilityand Sterility, 88, 310, 10.1016/j.fertnstert.2006.11.206

Chakhtoura, 2011, Progestogen-only contraceptives and the risk of acute myocardial infarction: a meta-analysis., J Clin Endocrinol Metab, 96, 1169, 10.1210/jc.2010-2065

Gillum, 2000, Ischemic stroke risk with oral contraceptives: A meta-analysis., JAMA, 284, 72, 10.1001/jama.284.1.72

Chan, 2004, Risk of stroke in women exposed to low-dose oral contraceptives: a critical evaluation of the evidence., Arch Intern Med, 164, 741, 10.1001/archinte.164.7.741

Baillargeon, 2005, Association between the current use of low-dose oral contraceptives and cardiovascular arterial disease: a meta-analysis., J Clin Endocrinol Metab, 90, 3863, 10.1210/jc.2004-1958

Gronich, 2011, Higher risk of venous thrombosis associated with drospirenone-containing oral contraceptives: a population-based cohort study., CMAJ, 183, e1319, 10.1503/cmaj.110463

Lidegaard, 2012, Venous thrombosis in users of nonoral hormonal contraception: follow-up study, Denmark 2001-10., BMJ, 344, e2990, 10.1136/bmj.e2990

Shufelt, 2009, Contraceptive hormone use and cardiovascular disease., J Am Coll Cardiol, 53, 221, 10.1016/j.jacc.2008.09.042

Lubianca, 2005, Stopping oral contraceptives: an effective blood pressure-lowering intervention in women with hypertension., J Hum Hypertens, 19, 451, 10.1038/sj.jhh.1001841

2006, 73: Use of hormonal contraception in women with coexisting medical conditions., Obstet Gynecol, 107, 1453, 10.1097/00006250-200606000-00055

Mosca, 2011, Effectiveness-based guidelinesforthe prevention ofcardiovasculardisease in women: 2011 update:aguideline fromthe American Heart Association., J Am Coll Cardiol, 57, 1404, 10.1016/j.jacc.2011.02.005

Collins, 2007, Managementofcardiovascularriskin the peri-menopausal woman: a consensus statement of European cardiologists and gynaecologists., Eur Heart J, 28, 2028, 10.1093/eurheartj/ehm296

Mueck, 2004, Effect ofhormone therapy on BP in normotensive and hypertensive postmenopausal women., Maturitas, 49, 189, 10.1016/j.maturitas.2004.01.010

Regitz-Zagrosek, 2011, ESC Guidelines on the management ofcardiovasculardiseasesduringpregnancy: the Task Forceonthe Managementof Cardiovascular Diseasesduring Pregnancyof the European Society of Cardiology (ESC)., Eur Heart J, 32, 3147, 10.1093/eurheartj/ehr218

Kuklina, 2011, Trends in pregnancy hospitalizationsthat included a stroke in the United States from 1994 to 2007: reasonsforconcern S, troke, 42, 2564

Martin, 2005, Strokeandseverepreeclampsiaand eclampsia: a paradigmshiftfocusingon systolic blood pressure., Obstet Gynecol, 105, 246, 10.1097/01.AOG.0000151116.84113.56

Duley, 2001, Antiplatelet drugs for prevention of preeclampsia and its consequences: systematic review., BMJ, 322, 329, 10.1136/bmj.322.7282.329

Rossi, 2011, Prevention ofpre-eclampsiawith low-dose aspirin orvitamins C and E in women at high or lowrisk: a systematic review with meta-analysis., Eur J Obstet Gynecol Reprod Biol, 158, 9, 10.1016/j.ejogrb.2011.04.010

Bujold, 2010, Prevention ofpreeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis., Obstet Gynecol, 116, 402, 10.1097/AOG.0b013e3181e9322a

Bellamy, 2007, Preeclampsia and risk ofcardiovascular disease and cancer in later life: systematic review and meta-analysis., BMJ, 335, 974, 10.1136/bmj.39335.385301.BE

McDonald, 2008, Cardiovascular sequelae of preeclampsiaeclampsia: a systematic review and meta-analyses., Am Heart J, 156, 918, 10.1016/j.ahj.2008.06.042

Beulens, 2009, Effectsofbloodpressureloweringandintensiveglucosecontrol on the incidence and progression ofretinopathy in patients with type 2 diabetes mellitus: a randomised controlled trial., Diabetologia, 52, 2027, 10.1007/s00125-009-1457-x

Chaturvedi, 2008, Effectofcandesartanon prevention (DIRECT-Prevent1) and progression (DIRECT-Protect1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials., Lancet, 372, 1394, 10.1016/S0140-6736(08)61412-9

Cederholm, 2012, Blood pressure and risk of cardiovascular disease in type 2 diabetes: further findings from the Swedish National Diabetes Register (NDR-BP-II)., J Hypertens, 30, 2020, 10.1097/HJH.0b013e3283577bdf

Cooper-De Hoff, 2010, Tight blood pressure control and cardiovascular outcomes among hypertensives patients with diabetes and coronary artery disease., JAMA, 304, 61, 10.1001/jama.2010.884

Schmieder, 2007, Renin-angiotensin system and cardiovascular risk., Lancet, 369, 1208, 10.1016/S0140-6736(07)60242-6

Alberti, 2009, Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity., Circulation, 120, 1640, 10.1161/CIRCULATIONAHA.109.192644

Benetos, 2008, All-cause and cardiovascular mortality using the different definitions of metabolic syndrome., Am J Cardiol, 102, 188, 10.1016/j.amjcard.2008.03.037

Nilsson, 2007, The metabolic syndrome and incidence of cardiovascular disease in nondiabetic subjects: a population-based study comparing three different definitions., Diabet Med, 24, 464, 10.1111/j.1464-5491.2007.02142.x

Mancia, 2007, Metabolic syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) study: daily life blood pressure, cardiac damage and prognosis., Hypertension, 49, 40, 10.1161/01.HYP.0000251933.22091.24

Shafi, 2008, 3rd, Klag MJ, Parekh RS. Changes in serum potassium mediate thiazide-induced diabetes., Hypertension, 52, 1022, 10.1161/HYPERTENSIONAHA.108.119438

Tuomilehto, 2001, Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance., N Engl J Med, 344, 1343, 10.1056/NEJM200105033441801

Knowler, 2002, Reduction in the incidence oftype 2 diabetes with lifestyle intervention or metformin., N Engl J Med, 346, 393, 10.1056/NEJMoa012512

Parati, 2012, Position paper on the management of patients with obstructive sleep apnea and hypertension: joint recommendations by the European Society of Hypertension, by the European Respiratory Society and by the members of European COST (Co-operation in Scientific and Technological research) ACTION B26 on obstructive sleep apnea., J Hypertens, 30, 633, 10.1097/HJH.0b013e328350e53b

Bazzano, 2007, Effect of nocturnal nasal continuous positive airway pressure on blood pressure in obstructive sleep apnea., Hypertension, 50, 417, 10.1161/HYPERTENSIONAHA.106.085175

Alajmi, 2007, Impact of continuous positive airway pressure therapy on blood pressure in patients with obstructive sleep apnea hypopnea: a meta-analysis of randomized controlled trials., Lung, 185, 67, 10.1007/s00408-006-0117-x

Mo, 2007, Effect of long-term continuous positive airway pressure ventilation on blood pressure in patients with obstructive sleep apnea hypopnea syndrome: a meta-analysis of clinical trials., Zhonghua yi xue za zhi, 87, 1177

Haentjens, 2007, The impact of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea syndrome: evidence from a meta-analysis of placebo-controlled randomized trials., Arch Intern Med, 167, 757, 10.1001/archinte.167.8.757

Kasiakogias, 2013, Effects of continuous positive airway pressure in hypertensive patients with obstructive sleep apnea: a 3-year follow-up., J Hypertens, 31, 352, 10.1097/HJH.0b013e32835bdcda

Barbe, 2012, Effect of continuous positive airway pressure on the incidence of hypertension and cardiovascular events in nonsleepy patients with obstructive sleep apnea: a randomized controlled trial., JAMA, 307, 2161, 10.1001/jama.2012.4366

Marin, 2012, Association between treated and untreated obstructive sleep apnea and risk of hypertension., JAMA, 307, 2169, 10.1001/jama.2012.3418

Zanchetti, 2012, What should be learnt about the management of obstructive sleep apnea in hypertension J H, ypertens, 30, 669, 10.1097/HJH.0b013e328351b988

Klag, 1997, End-stage renal disease in African-American and white men. 16-year MRFIT findings., JAMA, 277, 1293, 10.1001/jama.1997.03540400043029

Yano, 2012, Association between prehypertension and chronic kidney disease in the Japanese general population., Kidney Int, 81, 293, 10.1038/ki.2011.346

Jafar, 2003, Progression of chronic kidney disease: the role of blood pressure control, proteinuria and angiotensin-converting enzyme inhibition: a patient-level meta-analysis., Ann Intern Med, 139, 244, 10.7326/0003-4819-139-4-200308190-00006

Heerspink, 2009, Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trials., Lancet, 373, 1009, 10.1016/S0140-6736(09)60212-9

Lea, 2005, The relationship between magnitude of proteinuria reduction and risk of end-stage renal disease: results of the African American study of kidney disease and hypertension., Arch Intern Med, 165, 947, 10.1001/archinte.165.8.947

de Zeeuw, 2004, Albuminuria,atherapeutictargetforcardiovascularprotection in type 2 diabetic patients with nephropathy., Circulation, 110, 921, 10.1161/01.CIR.0000139860.33974.28

Schmieder, 2011, Changes in albuminuria predict mortality and morbidity in patients with vascular disease., J Am Soc Nephrol, 22, 1353, 10.1681/ASN.2010091001

Kunz, 2008, Meta-analysis: effect of monotherapy and combination therapy with inhibitors of the renin angiotensin system on proteinuria in renal disease., Ann Intern Med, 148, 30, 10.7326/0003-4819-148-1-200801010-00190

Ruggenenti, 2011, Effects of verapamil added-on trandolapril therapy in hypertensive type 2 diabetes patients with microalbuminuria: the BENEDICT-B randomized trial., J Hypertens, 29, 207, 10.1097/HJH.0b013e32834069bd

Bakris, 2010, ACCOMPLISH Trial InvestigatorsRenal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of randomised controlled trial., Lancet, 375, 1173, 10.1016/S0140-6736(09)62100-0

Pisoni, 2012, Long-term effects of aldosterone blockade in resistant hypertension associated with chronic kidney disease., J Hum Hypertens, 26, 502, 10.1038/jhh.2011.60

Levin, 2010, Blood pressure in chronic kidney disease stage 5D-report from a Kidney Disease: Improving Global Outcomes controversies conference., Kidney Int, 77, 273, 10.1038/ki.2009.469

Potter, 2009, Controlling hypertension and hypotension immediately poststroke (CHHIPS): a randomised, placebocontrolled, double-blind pilot trial., Lancet Neurology, 8, 48, 10.1016/S1474-4422(08)70263-1

Schrader, 2003, The ACCESS Study: evaluation of Acute Candesartan Cilexetil Therapy in Stroke Survivors., Stroke, 34, 1699, 10.1161/01.STR.0000075777.18006.89

Sandset, 2011, The angiotensin-receptor blocker candesartan fortreatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial., Lancet, 377, 741, 10.1016/S0140-6736(11)60104-9

Fuentes Patarroyo, 2012, Blood Pressure Lowering in Acute Phase of Stroke, Latest Evidence and Clinical Implication., Ther Adv Chronic Dis, 3, 163, 10.1177/2040622312450183

Gueyffier, 1997, Effect of antihypertensive treatment in patients having already suffered from stroke. Gathering the evidence. The INDANA (INdividual Data ANalysis of Antihypertensive intervention trials) Project Collaborators., Stroke, 28, 2557, 10.1161/01.STR.28.12.2557

Schrader, 2005, MOSES Study GroupMorbidity and mortality after stroke, eprosartan compared with nitrendipine for secondary prevention: principal results of a prospective randomized controlled study (MOSES)., Stroke, 36, 1218, 10.1161/01.STR.0000166048.35740.a9

Reboldi, 2008, Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a meta-analysis., J Hypertens, 26, 1282, 10.1097/HJH.0b013e328306ebe2

Ninomiya, 2011, Midlife and late-life blood pressure and dementia in Japanese elderly: the Hisayama study., Hypertension, 58, 22, 10.1161/HYPERTENSIONAHA.110.163055

Peters, 2008, Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial., Lancet Neurology, 7, 683, 10.1016/S1474-4422(08)70143-1

Dufouil, 2009, Severe cerebral white matter hypersensities predict severe cognitive decline in patients with cerebrovascular disease history., Stroke, 40, 2219, 10.1161/STROKEAHA.108.540633

Godin, 2011, Antihypertensive treatment and change in blood pressure are associated with the progression of white matter lesion volumes: the Three-City (3C)-Dijon Magnetic Resonance Imaging Study., Circulation, 123, 266, 10.1161/CIRCULATIONAHA.110.961052

Yusuf, 2004, INTERHEART Study InvestigatorsEffect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study., Lancet, 364, 937, 10.1016/S0140-6736(04)17018-9

2009, 900000 adults: collaborative analyses of 57 prospective studies., Lancet, 373, 1083, 10.1016/S0140-6736(09)60318-4

Borghi, 1999, Effects of the administration of an angiotensin converting enzyme inhibitor during the acute phase of myocardial infarction in patients with arterial hypertension. SMILE Study Investigators. Survival of Myocardial Infarction Long Term Evaluation., Am J Hypertens, 12, 665, 10.1016/S0895-7061(99)00042-4

Gustafsson, 1998, Long-term prognosis after acute myocardial infarction in patients with a history of arterial hypertension., Eur Heart J, 4, 588, 10.1053/euhj.1997.0822

Tocci, 2008, Development of heart failure in recent hypertension trials., J Hypertens, 26, 1477, 10.1097/HJH.0b013e3282fe1d3d

2008, Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial., Lancet, 372, 1174, 10.1016/S0140-6736(08)61242-8

Raphael, 2009, Quantifying the paradoxical effect of higher systolic blood pressure on mortality in chronic heart failure., Heart, 95, 56, 10.1136/hrt.2007.134973

Massie, 2008, Irbesartan in patients with heart failure and preserved ejection fraction., N Engl J Med, 359, 2456, 10.1056/NEJMoa0805450

Camm, 2010, Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)., Eur Heart J, 31, 2369, 10.1093/eurheartj/ehq278

Grundvold, 2012, Upper normal blood pressures predict incident atrial fibrillation in healthy middle-aged men: a35-yearfollow-up study., Hypertension, 59, 198, 10.1161/HYPERTENSIONAHA.111.179713

Manolis, 2012, Hypertension and atrial fibrillation: diagnostic approach, prevention and treatment. Position paper of the Working Group Hypertension Arrhythmias and Thrombosis of the European Society of Hypertension., J Hypertens, 30, 239, 10.1097/HJH.0b013e32834f03bf

Hart, 2007, Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation., Ann Intern Med, 146, 857, 10.7326/0003-4819-146-12-200706190-00007

Camm, 2012, 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: An update of the 2010 ESC Guidelines for the management of atrial fibrillation., Eur Heart J, 33, 2719, 10.1093/eurheartj/ehs253

Arima, 2012, Effects of blood pressure lowering on intracranial and extracranial bleeding in patients on antithrombotic therapy: the PROGRESS trial., Stroke, 43, 1675, 10.1161/STROKEAHA.112.651448

Wachtell, 2005, Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared with atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study., J Am Coll Cardiol, 45, 712, 10.1016/j.jacc.2004.10.068

Schmieder, 2008, Reduced incidence of new-onset atrial fibrillation with angiotensin II receptor blockade: the VALUE trial., J Hypertens, 26, 403, 10.1097/HJH.0b013e3282f35c67

Cohn, 2001, A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure., N Engl J Med, 345, 1667, 10.1056/NEJMoa010713

Vermes, 2003, Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the Studies Of Left Ventricular Dysfunction (SOLVD) trials., Circulation, 107, 2926, 10.1161/01.CIR.0000072793.81076.D4

Ducharme, 2006, Prevention of atrialfibrillationinpatientswithsymptomaticchronicheartfailurebycandesartaninthe Candesartanin Heartfailure:Assessmentof Reductionin Mortalityandmorbidity(CHARM) program., Am Heart J, 152, 86, 10.1016/j.ahj.2005.06.036

2011, N Engl J M, ed, 364, 928

Tveit, 2007, Candesartan in the prevention of relapsing atrial fibrillation., Int J Cardiol, 120, 85, 10.1016/j.ijcard.2006.08.086

2009, N Engl J M, ed, 360, 1606

Goette, 2012, Angiotensin II-antagonist in paroxysmal atrial fibrillation (ANTIPAF) trial., Circulation Arrhythmia and Electrophysiology, 5, 43, 10.1161/CIRCEP.111.965178

Schneider, 2010, Prevention of atrial fibrillation by renin-angiotensin system inhibition: a meta-analysis., J Am Coll Cardiol, 55, 2299, 10.1016/j.jacc.2010.01.043

Nasr, 2007, Prevention of atrial fibrillation onset by beta-blocker treatment in heart failure: a meta-analysis., Eur Heart J, 28, 457, 10.1093/eurheartj/ehl484

Swedberg, 2012, EMPHASIS-HF Study InvestigatorsEplerenone and atrial fibrillation in mild systolic heart failure: results from the EMPHASIS-HF (Eplerenone in Mild Patients Hospitalization And Surv Ival Study in Heart Failure) study., J Am Coll Cardiol, 59, 1598, 10.1016/j.jacc.2011.11.063

Schaer, 2010, Risk for incident atrial fibrillation in patients who receive antihypertensive drugs: a nested case-control study., Ann Intern Med, 152, 78, 10.7326/0003-4819-152-2-201001190-00005

Fagard, 2009, Regression of left ventricular mass by antihypertensive treatment: a meta-analysis of randomized comparative studies., Hypertension, 54, 1084, 10.1161/HYPERTENSIONAHA.109.136655

Zanchetti, 2004, Different effects of antihypertensive regimens based on fosinopril or hydrochlorothiazide with or without lipid lowering by pravastatin on progression of asymptomatic carotid atherosclerosis: principal results of PHYLLIS: a randomized double-blind trial., Stroke, 35, 2807, 10.1161/01.STR.0000147041.00840.59

Ong, 2011, Aortic stiffness is reduced beyond blood pressure lowering by short-term and long-term antihypertensive treatment: a meta-analysis of individual data in 294 patients., J Hypertens, 29, 1034, 10.1097/HJH.0b013e328346a583

Shahin, 2012, Angiotensin converting enzyme inhibitors effect on arterial stiffness and wave reflections: a meta-analysis and meta-regression of randomised controlled trials., Atherosclerosis, 221, 18, 10.1016/j.atherosclerosis.2011.12.005

Karalliedde, 2008, Ferber P, Viberti G. Valsartan improves arterial stiffness in type 2 diabetes independently of blood pressure lowering., Hypertension, 51, 1617, 10.1161/HYPERTENSIONAHA.108.111674

Ait Oufella, 2010, Long-term reduction in aortic stiffness: a 5.3 year follow-up in routine clinical practice., J Hypertens, 28, 2336, 10.1097/HJH.0b013e32833da2b2

Guerin, 2001, Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure., Circulation, 103, 987, 10.1161/01.CIR.103.7.987

Singer, 2008, Management of hypertension in peripheral arterial disease: does the choice of drugs matter Eur J Vasc Endovasc S, urg, 35, 701

2000, Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients., NEngl J Med, 342, 145, 10.1056/NEJM200001203420301

Paravastu, 2009, Beta blockers for peripheral arterial disease., Eur J Vasc Endovasc Surg, 38, 66, 10.1016/j.ejvs.2009.02.019

Radack, 1991, Beta-adrenergic blocker therapy does not worsen intermittent claudication in subjects with peripheral arterial disease. A meta-analysis of randomized controlled trials., Arch Intern Med, 151, 1769, 10.1001/archinte.1991.00400090063012

Dong, 2011, Erectile dysfunction and risk of cardiovascular disease: meta-analysis of prospective cohort studies., J Am Coll Cardiol, 58, 1378, 10.1016/j.jacc.2011.06.024

Gupta, 2011, The effect of lifestyle modification and cardiovascular risk factor reduction on erectile dysfunction: a systematic review and meta-analysis., Arch Intern Med, 171, 1797, 10.1001/archinternmed.2011.440

Manolis, 2008, Sexual dysfunction: the prima ballerina of hypertension-related quality-of-life complications., J Hypertens, 26, 2074, 10.1097/HJH.0b013e32830dd0c6

Pickering, 2004, Sildenafil citrate for erectile dysfunction in men receiving multiple antihypertensive agents: a randomized controlled trial., Am J Hypertens, 17, 1135, 10.1016/j.amjhyper.2004.07.004

Scranton, 2007, Effect of treating erectile dysfunction on management of systolic hypertension., Am J Cardiol, 100, 459, 10.1016/j.amjcard.2007.03.045

Ma, 2012, Effect of felodipine with irbesartan or metoprolol on sexual function and oxidative stress in women with essential hypertension., J Hypertens, 30, 210, 10.1097/HJH.0b013e32834e1e2e

Fagard, 2012, Resistant hypertension., Heart, 98, 254, 10.1136/heartjnl-2011-300741

De la Sierra, 2011, Clinicalfeaturesof8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring., Hypertension, 57, 171, 10.1161/HYPERTENSIONAHA.110.168948

Daugherty, 2012, Incidence and prognosis of resistant hypertension in hypertensive patients., Circulation, 125, 1635, 10.1161/CIRCULATIONAHA.111.068064

Persell, 2011, Prevalence of resistant hypertension in the United States, 2003-2008., Hypertension, 57, 1076, 10.1161/HYPERTENSIONAHA.111.170308

Mantero, 2007, Detecting and treating primary aldosteronism: primary aldosteronism., Exp Clin Endocrinol Diabetes, 115, 171, 10.1055/s-2007-970409

Redon, 1998, Prognostic value of ambulatory blood pressure monitoring in refractory hypertension: a prospective study., Hypertension, 31, 712, 10.1161/01.HYP.31.2.712

Yakovlevitch, 1991, Resistant hypertension in a tertiary care clinic., Arch Intern Med, 151, 1786, 10.1001/archinte.1991.00400090078014

Zannad, 2007, Aldosterone antagonist therapy in resistant hypertension., J Hypertens, 25, 747, 10.1097/HJH.0b013e3280d9434e

Lane, 2007, Low-dose spironolactone in the management of resistant hypertension: a surveillance study., J Hypertens, 25, 891, 10.1097/HJH.0b013e328014954d

Vaclavik, 2011, Addition of spironolactone in patients with resistant arterial hypertension (ASPIRANT): a randomized, double-blind, placebo-controlled trial., Hypertension, 57, 1069, 10.1161/HYPERTENSIONAHA.111.169961

Chapman, 2008, Effect of doxazosin gastrointestinal therapeutic system as third-line antihypertensive therapy on blood pressure and lipids in the Anglo-Scandinavian Cardiac Outcomes Trial., Circulation, 118, 42, 10.1161/CIRCULATIONAHA.107.737957

Bobrie, 2012, Sequential nephron blockade vs. sequential renin-angiotensin system blockade in resistant hypertension: a prospective, randomized, open blinded endpoint study., J Hypertens, 30, 1656, 10.1097/HJH.0b013e3283551e98

Gaddam, 2008, Characterization of resistant hypertension: association between resistant hypertension, aldosterone and persistent intravascular volume expansion., Arch Intern Med, 168, 1159, 10.1001/archinte.168.11.1159

Lijnen, 1982, Increase in plasma aldosterone during prolonged captopril treatment., Am J Cardiol, 49, 1561, 10.1016/0002-9149(82)90390-3

Weber, 2009, A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial., Lancet, 374, 1423, 10.1016/S0140-6736(09)61500-2

Bakris, 2010, Divergent results using clinic and ambulatory blood pressures: report of a darusentan-resistant hypertension trial., Hypertension, 56, 824, 10.1161/HYPERTENSIONAHA.110.156976

Laurent, 2012, New drugs procedures and devices for hypertension., Lancet, 380, 591, 10.1016/S0140-6736(12)60825-3

Bisognano, 2011, Baroreflex activation therapy lowers blood pressure in patients with resistant hypertension: results from the double-blind, randomized, placebo-controlled rheos pivotal trial., J Am Coll Cardiol, 58, 765, 10.1016/j.jacc.2011.06.008

Bakris, 2012, Baroreflex activation therapy provides durable benefit in patients with resistant hypertension: results of longterm follow-up in the Rheos Pivotal Trial., J Am Soc Hypertens, 6, 152, 10.1016/j.jash.2012.01.003

Hoppe, 2012, Minimally invasive system for baroreflex activation therapy chronically lowers blood pressure with pacemaker-like safety profile: results from the Barostim Neo trial., J Am Soc Hypertens, 6, 270, 10.1016/j.jash.2012.04.004

Krum, 2009, Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study., Lancet, 373, 1275, 10.1016/S0140-6736(09)60566-3

Simplicity, 2011, 1 InvestigatorsCatheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months., Hypertension, 57, 911, 10.1161/HYPERTENSIONAHA.110.163014

2010, 2 Trial): a randomised controlled trial., Lancet, 376, 1903

Geisler, 2012, Cost-effectiveness and clinical effectiveness of catheter-based renal denervation for resistant hypertension., J Am Coll Cardiol, 60, 1271, 10.1016/j.jacc.2012.07.029

Esler, 1989, Regional norepinephrine turnover in human hypertension., Clin Exp Hypertens, 11, 75

Grassi, 1998, Baroreflex Control of sympathetic nerve activity in essential and secondary hypertension., Hypertension, 31, 68, 10.1161/01.HYP.31.1.68

Grassi, 2000, Adrenergic and reflex abnormalities in obesity-related hypertension., Hypertension, 36, 538, 10.1161/01.HYP.36.4.538

Stella, 1991, Functional role of renal afferents., Physiol Rev, 71, 659, 10.1152/physrev.1991.71.3.659

Di Bona, 1997, Neural control of renal function., Physiol Rev, 77, 75, 10.1152/physrev.1997.77.1.75

Doumas, 2012, Should ambulatory blood pressure monitoring be mandatory for future studies in resistant hypertension:a perspective., Hypertension, 30, 874, 10.1097/HJH.0b013e328352c3c7

Brandt, 2012, Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension., J Am Coll Cardiol, 59, 901, 10.1016/j.jacc.2011.11.034

Mahfoud, 2011, Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study., Circulation, 123, 1940, 10.1161/CIRCULATIONAHA.110.991869

Mahfoud, 2012, Renal haemodynamics and renal function after catheter-based renal sympathetic denervation in patients with resistant hypertension., Hypertension, 60, 419, 10.1161/HYPERTENSIONAHA.112.193870

Schmieder, 2012, ESH position paper: renal denervation: an interventionaltherapy of resistant hypertension., J Hypertens, 30, 837, 10.1097/HJH.0b013e328352ce78

Frank, 2009, Temporary reduction of blood pressure and sympathetic nerve activity in hypertensive patients after microvascular decompression., Stroke, 40, 47, 10.1161/STROKEAHA.108.518670

Zhang, 2012, FEVER Study GroupHigher cardiovascular risk and impaired benefit of antihypertensve treatment in hypertensive patients requiring additional drugs on top of randomized therapy: is adding drugs always beneficial J H, ypertens, 30, 2202, 10.1097/HJH.0b013e3283582eec

Weber, 2012, Cardiovascular outcomes in hypertensive patients: comparing single-agent therapy with combination therapy., J Hypertens, 30, 2213, 10.1097/HJH.0b013e3283582ed6

Lane, 2009, Improving survival of malignant hypertension patients over 40 years., Am J Hypertens, 22, 1199, 10.1038/ajh.2009.153

Gosse, 2011, Impact of malignant arterial hypertension on the heart., J Hypertens, 29, 798, 10.1097/HJH.0b013e3283430b12

Gonzalez, 2010, Long-term renal survival in malignant hypertension., Nephrol Dial Transplant, 25, 3266, 10.1093/ndt/gfq143

Casadei, 2005, Is there a strong rationale for deferring elective surgery in patients with poorly controlled hypertension J H, ypertens, 23, 19, 10.1097/00004872-200501000-00005

Manolis, 2010, Perioperative screening and management of hypertensive patients., European Society of Hypertension Scientific Newsletter, 11, 2

Pearce, 2006, Progression of atherosclerotic renovascular disease: A prospective population-based study., J Vasc Surg, 44, 955, 10.1016/j.jvs.2006.07.031

Safian, 2001, Renal-artery stenosis., N Engl J Med, 344, 431, 10.1056/NEJM200102083440607

Gray, 2002, Clinical benefit of renal artery angioplasty with stenting for the control of recurrent and refractory congestive heart failure., Vasc Med, 7, 275, 10.1191/1358863x02vm456oa

Wheatley, 2009, Revascularization vs. medical therapy for renal-artery stenosis., N Engl J Med, 361, 1953, 10.1056/NEJMoa0905368

Funder, 2008, Case detection, diagnosis and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline., J Clin Endocrinol Metab, 93, 3266, 10.1210/jc.2008-0104

Sawka, 2001, Primary aldosteronism: factors associated with normalization of blood pressure after surgery., Ann Intern Med, 135, 258, 10.7326/0003-4819-135-4-200108210-00010

Rossi, 2008, Vascular remodeling and duration of hypertension predict outcome of adrenalectomy in primary aldosteronism patients., Hypertension, 51, 1366, 10.1161/HYPERTENSIONAHA.108.111369

Parthasarathy, 2011, Adouble-blind,randomizedstudycomparing the antihypertensive effect of eplerenone and spironolactone in patients with hypertension and evidence of primary aldosteronism., J Hypertens, 29, 980, 10.1097/HJH.0b013e3283455ca5

Chapman, 2011, and for the European Atherosclerosis Society Consensus PanelTriglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management., Eur Heart J, 32, 1345, 10.1093/eurheartj/ehr112

Sever, 2003, ASCOT InvestigatorsPrevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial: Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial., Lancet, 361, 1149, 10.1016/S0140-6736(03)12948-0

2002, Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT)., JAMA, 288, 2998, 10.1001/jama.288.23.2998

Sever, 2009, ASCOT InvestigatorsAntihypertensive therapy and the benefits of atorvastatin in the Anglo-Scandinavian Cardiac Outcomes Trial: lipid-lowering arm extension., J Hypertens, 27, 947, 10.1097/HJH.0b013e328326cb1a

Ridker, 2008, JUPITER Study GroupRosuvastatin to prevent vascular events in men and women with elevated C-reactive protein., N Engl J Med, 359, 2195, 10.1056/NEJMoa0807646

Reiner, 2011, ESCEAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology ESC) and the European Atherosclerosis Society (EAS)., Eur Heart J, 32, 1769, 10.1093/eurheartj/ehr158

Baigent, 2010, Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170000 participants in 26 randomised trials., Lancet, 376, 1670, 10.1016/S0140-6736(10)61350-5

Amarenco, 2006, 3rd, Goldstein LB, Hennerici M, Rudolph AE, et al. Stroke Prevention by aggressive reduction in cholesterol levels (SPARCL) investigators. High-dose atorvastatin after stroke or transient ischemic attack., N Engl J Med, 355, 549

Baigent, 2009, Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials., Lancet, 373, 1849, 10.1016/S0140-6736(09)60503-1

Jardine, 2010, Aspirin is beneficial in hypertensive patients with chronic kidney disease: a posthoc subgroup analysis of a randomized controlled trial., J Am Coll Cardiol, 56, 956, 10.1016/j.jacc.2010.02.068

Rothwell, 2012, Short-term effects of daily aspirin on cancer incidence, mortality and nonvascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials., Lancet, 379, 1602, 10.1016/S0140-6736(11)61720-0

Nathan, 2005, Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes., N Engl J Med, 353, 2643, 10.1056/NEJMoa052187

Polak, 2011, DCCTEDIC Research GroupProgression of carotid artery intima-media thickness during 12 years in the Diabetes Control and Complications TrialEpidemiology of Diabetes Interventions and Complications (DCCTEDIC) study., Diabetes, 60, 607, 10.2337/db10-0296

1998, 2 diabetes (UKPDS 33)., Lancet, 352, 837

1998, 2 diabetes (UKPDS 34)., Lancet, 352, 854

2008, 2 diabetes., N Engl J Med, 358, 2560

Gerstein, 2011, Long-term effects of intensive glucose lowering on cardiovascular outcomes., N Engl J Med, 364, 818, 10.1056/NEJMoa1006524

Duckworth, 2009, Glucose control and vascular complications in veterans with type 2 diabetes., N Engl J Med, 360, 129, 10.1056/NEJMoa0808431

Ray, 2009, Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials., Lancet, 373, 1765, 10.1016/S0140-6736(09)60697-8

Turnbull, 2009, Intensive glucose control and macrovascular outcomes in type 2 diabetes., Diabetologia, 52, 2288, 10.1007/s00125-009-1470-0

Hemmingsen, 2011, Intensive glycaemic control for patients with type 2 diabetes: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials., BMJ, 343, d6898, 10.1136/bmj.d6898

Inzucchi, 2012, Management of hyperglycaemia in type 2 diabetes: a patient- centreed approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)., Diabetologia, 55, 1577, 10.1007/s00125-012-2534-0

Ferrannini, 2012, SGLT2 inhibition in diabetes mellitus: rationale and clinical prospects., Nature Rev Endocrinol, 8, 495, 10.1038/nrendo.2011.243

Birtwhistle, 2004, Randomised equivalence trial comparing three month and six month follow up of patients with hypertension by family practitioners., BMJ, 328, 204, 10.1136/bmj.37967.374063.EE

Clark, 2010, Nurse led interventionsto improve controlof blood pressure in peoplewith hypertension: systematic reviewand meta-analysis., BMJ, 341, c3995, 10.1136/bmj.c3995

Niiranen, 2010, Home-measured blood pressure is a stronger predictor of cardiovascular risk than office blood pressure: the Finn- Home study., Hypertension, 55, 1346, 10.1161/HYPERTENSIONAHA.109.149336

Bray, 2010, Does self-monitoring reduce blood pressure Meta-analysis with meta-regression of randomized controlled trials., Ann Med, 42, 371, 10.3109/07853890.2010.489567

McManus, 2010, Telemonitoring and self-management in the controlof hypertension (TASMINH2): a randomised controlled trial., Lancet, 376, 163, 10.1016/S0140-6736(10)60964-6

Gupta, 2010, Prehypertension in disease-free adults: a marker for an adverse cardiometabolic risk profile., Hypertens Res, 33, 905, 10.1038/hr.2010.91

Thompson, 2011, Antihypertensive treatment and secondary prevention of cardiovascular disease events among persons without hypertension: a meta-analysis., JAMA, 305, 913, 10.1001/jama.2011.250

Sacks, 2001, Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group., N Engl J Med, 344, 3, 10.1056/NEJM200101043440101

Viera, 2011, Do physicians tell patients they have prehypertension JAm Board Family M, ed, 24, 117

Faria, 2009, A narrative review of clinical inertia: focus on hypertension., J Am Soc Hypert, 3, 267, 10.1016/j.jash.2009.03.001

Kearney, 2004, Worldwide prevalence of hypertension: a systematic review., J Hypertens, 22, 11, 10.1097/00004872-200401000-00003

Muiesan, 2007, Inappropriate left ventricular mass changes during treatment adversely affects cardiovascular prognosis in hypertensive patients., Hypertension, 49, 1077, 10.1161/HYPERTENSIONAHA.107.087320

Okin, 2011, Serial assessment of the electrocardiographic strain pattern for prediction of new-onset heart failure during antihypertensive treatment: the LIFE study., Eur J Heart Fail, 13, 384, 10.1093/eurjhf/hfq224

Gerdts, 2007, Left atrial size and risk of major cardiovascular events during antihypertensive treatment: losartan intervention for endpoint reduction in hypertension trial., Hypertension, 49, 311, 10.1161/01.HYP.0000254322.96189.85

Olsen, 2006, Reductions in albuminuria and in electrocardiographic left ventricular hypertrophy independently improve prognosis in hypertension: the LIFE study., J Hypertens, 24, 775, 10.1097/01.hjh.0000217862.50735.dc

Atkins, 2005, Proteinuria reduction and progression to renal failure in patients with type 2 diabetes mellitus and overt nephropathy., Am J Kidney Dis, 45, 281, 10.1053/j.ajkd.2004.10.019

Costanzo, 2010, Does carotid intima-media thickness regression predict reduction of cardiovascular events A meta-analysis of 41 randomized trials., J Am Coll Cardiol, 56, 2006, 10.1016/j.jacc.2010.05.059

Goldberger, 2010, Are changes in carotid intima-media thickness related to risk of nonfatal myocardial infarction A critical review and meta-regression analysis., Am Heart J, 160, 701, 10.1016/j.ahj.2010.06.029

Bots, 2012, Rate of exchange in carotid intima-media thickness and vascular events: meta-analyses can not solve all the issues. A point of view., J Hypertens, 30, 1690, 10.1097/HJH.0b013e32835644dc

Burt, 1995, Trends in the prevalence, awareness, treatment and controlof hypertension in the adult US population. Data from the Health Examination Surveys, 1960 to 1991., Hypertension, 26, 60, 10.1161/01.HYP.26.1.60

Reiner, 2010, Physicians perception. knowledge and awareness ofcardiovacsulr risk factors and adherence to prevention guidelines: the PERCRO-DOC survey., Atherosclerosis, 213, 598, 10.1016/j.atherosclerosis.2010.09.014

Amar, 2003, Why is hypertension so frequently uncontrolled in secondary prevention J H, ypertens, 21, 1199, 10.1097/00004872-200306000-00021

Mancia, 2005, Blood pressure control and risk of stroke in untreated and treated hypertensive patients screened from clinical practice: results of the For Life study., J Hypertens, 23, 1575, 10.1097/01.hjh.0000175932.78774.32

Benetos, 2003, Why cardiovascular mortality is higher in treated hypertensives vs. subjects of the same age, in the general population., J Hypertens, 21, 1635, 10.1097/00004872-200309000-00011

Redon, 2007, Differences in blood pressure control and stroke mortality across Spain: the Prevencion de Riesgo de Ictus (PREV-ICTUS) study., Hypertension, 49, 799, 10.1161/01.HYP.0000259104.60878.43

Kotseva, 2009, Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II and III surveys in eight European countries., Lancet, 373, 929, 10.1016/S0140-6736(09)60330-5

Bhatt, 2006, International prevalence, recognition and treatment of cardiovascular risk factors in outpatients with atherothrombosis., JAMA, 295, 180, 10.1001/jama.295.2.180

Cooper-De Hoff, 2009, INVEST revisited: review of findings from the International Verapamil SR-Trandolapril Study., Expert Rev Cardiovasc Ther, 7, 1329, 10.1586/erc.09.102

Ezzati, 2002, Selected major risk factors and global and regional burden of disease., Lancet, 360, 1347, 10.1016/S0140-6736(02)11403-6

Banegas, 2004, Blood pressure control and physician management of hypertension in hospital hypertension units in Spain., Hypertension, 43, 1338, 10.1161/01.HYP.0000127424.59774.84

Corrao, 2008, Discontinuation of and changes in drug therapy for hypertension among newly-treated patients: a population-based study in Italy., J Hypertens, 26, 819, 10.1097/HJH.0b013e3282f4edd7

Lee, 2006, Effect of a pharmacy care program on medication adherence and persistence, blood pressure and low-density lipoprotein cholesterol: a randomized controlled trial., JAMA, 296, 2563, 10.1001/jama.296.21.joc60162

Gale, 2011, Patient and general practitioner attitudes to taking medication to prevent cardiovascular disease after receiving detailed information on risks and benefits of treatment: a qualitative study., BMC Family Practice, 12, 59, 10.1186/1471-2296-12-59

Krousel-Wood, 2011, Predictors of decline in medication adherence: results from the cohort study of medication adherence among older adults., Hypertension, 58, 804, 10.1161/HYPERTENSIONAHA.111.176859

Corrao, 2011, Better compliance to antihypertensive medications reduces cardiovascular risk., J Hypertens, 29, 610, 10.1097/HJH.0b013e328342ca97

Mazzaglia, 2009, Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients., Circulation, 120, 1598, 10.1161/CIRCULATIONAHA.108.830299

Vrijens, 2008, Adherence to prescribed antihypertensive drugtreatments: longitudinal study of electronically compiled dosing histories., BMJ, 336, 1114, 10.1136/bmj.39553.670231.25

Redon, 2010, Factors associated with therapeutic inertia in hypertension: validation of a predictive model., J Hypertens, 28, 1770, 10.1097/HJH.0b013e32833b4953

Luders, 2010, Improvement of hypertension management by structured physician education and feedback system: cluster randomized trial., Eur J Cardiovasc Prev Rehabil, 17, 271, 10.1097/HJR.0b013e328330be62

De Rivas, 2010, Effectiveness of an Interventional Program to Improve Blood Pressure Control in Hypertensive Patients at High Risk for Developing Heart Failure: HEROIC study., J Clin Hypertens (Greenwich), 12, 335, 10.1111/j.1751-7176.2010.00271.x

Guthrie, 2007, Tackling therapeutic inertia: role of treatment data in quality indicators., BMJ, 335, 542, 10.1136/bmj.39259.400069.AD

Claxton, 2001, A systematic review of the associations between dose regimens and medication compliance., Clin Ther, 23, 1296, 10.1016/S0149-2918(01)80109-0

Ashworth, 2008, Effect of social deprivation on blood pressure monitoring and control in England: a survey of data from the quality and outcomes framework., BMJ, 337, a2030, 10.1136/bmj.a2030

Serumaga, 2011, Effect ofpayfor performance on the management and outcomes of hypertension inthe United Kingdom: interrupted time series study., BMJ, 342, d108, 10.1136/bmj.d108

Campbell, 2009, Effects ofpayfor performance on the quality of primary care in England., N Engl J Med, 361, 368, 10.1056/NEJMsa0807651

Fahey, 2005, Educational and organisational interventions used to improve the management of hypertension in primary care: a systematic review., Br J Gen Pract, 55, 875

Weingarten, 2002, Interventions used in disease management programmes for patients with chronic illness- which ones work Meta-analysis of published reports., BMJ, 325, 925, 10.1136/bmj.325.7370.925

Carter, 2012, The hypertension team: the role of the pharmacist, nurse and teamwork in hypertension therapy., J Clin Hypertens (Greenwich), 14, 51, 10.1111/j.1751-7176.2011.00542.x

Chodosh, 2005, Meta-analysis: chronic disease self-management programs for older adults., Ann Intern Med, 143, 427, 10.7326/0003-4819-143-6-200509200-00007

Carter, 2009, The potency ofteam-based care interventions for hypertension: a meta-analysis., Arch Intern Med, 169, 1748, 10.1001/archinternmed.2009.316

Walsh, 2006, Quality improvement strategies for hypertension management: a systematic review., Med Care, 44, 646, 10.1097/01.mlr.0000220260.30768.32

Machado, 2007, Sensitivity of patient outcomes to pharmacist interventions. Part II: Systematic review and meta-analysis in hypertension management., Ann Pharmacother, 41, 1770, 10.1345/aph.1K311

Morak, 2012, Design and evaluation of a telemonitoring concept based on NFC-enabled mobile phones and sensor devices., IEEE transactions on information technology in biomedicine: a publication of the IEEE Engineering in Medicine and Biology Society, 16, 17, 10.1109/TITB.2011.2176498

Canzanello, 2005, Inferred blood pressure control with a physician-nurseteam and home BP measurement., Mayo Clin Proc, 80, 31, 10.1016/S0025-6196(11)62954-6

Stergiou, 2010, Setting-up a blood pressure and vascular protection clinic: requirements of the European Society of Hypertension., J Hypertens, 28, 1780, 10.1097/HJH.0b013e32833d1e01

Shea, 2012, Telehomecare communication and self-care in chronic conditions: moving toward a shared understanding., Worldviews on evidence-based nursingSigma Theta Tau International, Honor Society of Nursing, 9, 109, 10.1111/j.1741-6787.2012.00242.x

Parati, 2009, Home blood pressure telemonitoring improves hypertension control in general practice. The Tele BPCare study., J Hypertens, 27, 198, 10.1097/HJH.0b013e3283163caf

Neumann, 2011, Blood pressure telemonitoring is useful to achieve blood pressure control in inadequately treated patients with arterial hypertension., J Hum Hypertens, 25, 732, 10.1038/jhh.2010.119

Omboni, 2011, Impact of home blood pressure telemonitoring and blood pressure control: a meta-analysis of randomized controlled studies., Am J Hypertens, 24, 989, 10.1038/ajh.2011.100

Russell, 2009, Service developments for managing people with long-term conditions using case management approaches, an example from the UK., International J Integrated Care, 9, e02, 10.5334/ijic.303